Document:

SECURITIES PURCHASE AGREEMENT

      This  Securities  Purchase  Agreement  (this  "Agreement")  is dated as of
September 22, 2005, by and among Accupoll  Holding  Corp., a Nevada  corporation
(the  "Company"),  and the purchasers  identified on the signature  pages hereto
(each,  including its successors and assigns, a "Purchaser" and collectively the
"Purchasers").

      WHEREAS,  subject to the terms and  conditions set forth in this Agreement
and pursuant to Section 4(2) of the Securities Act (as defined below),  and Rule
506  promulgated  thereunder,  the  Company  desires  to issue  and sell to each
Purchaser,  and each Purchaser,  severally and not jointly,  desires to purchase
from the  Company in the  aggregate,  up to $3 million  of  Preferred  Stock and
Warrants on the Closing Date.

      NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this
Agreement,  and for  other  good and  valuable  consideration  the  receipt  and
adequacy of which are hereby acknowledged,  the Company and each Purchaser agree
as follows:

                                    ARTICLE I
                                   DEFINITIONS

      1.1  Definitions.  In  addition  to the terms  defined  elsewhere  in this
Agreement:  (a) capitalized terms that are not otherwise defined herein have the
meanings  given to such terms in the  Certificate  of  Designation  (as  defined
herein), and (b) the following terms have the meanings indicated in this Section
1.1:

      "Action" shall have the meaning ascribed to such term in Section 3.1(j).

            "Actual Minimum" means, as of any date, the maximum aggregate number
      of shares of Common  Stock  then  issued or  potentially  issuable  in the
      future  pursuant to the  Transaction  Documents,  including any Underlying
      Shares  issuable  upon  exercise or conversion in full of all Warrants and
      shares of Preferred Stock,  ignoring any conversion or exercise limits set
      forth  therein,  and assuming that any  previously  unconverted  shares of
      Preferred  Stock are held until the fifth  anniversary of the Closing Date
      and all  dividends  are paid in shares of Common  Stock  until  such third
      anniversary,  subject to the  limitation on the number of shares of Common
      Stock issuable hereunder set forth in Section 5(a)(iii) of the Certificate
      of Designation.

            "Affiliate"  means any Person that,  directly or indirectly  through
      one or more  intermediaries,  controls  or is  controlled  by or is  under
      common  control  with a Person,  as such  terms are used in and  construed
      under Rule 144 under the Securities Act. With respect to a Purchaser,  any
      investment  fund or managed  account  that is  managed on a  discretionary
      basis by the same  investment  manager as such Purchaser will be deemed to
      be an Affiliate of such Purchaser.

                                        1
<PAGE>

            "Certificate of Designation" means the Certificate of Designation to
      be filed prior to the Closing by the Company  with the  Secretary of State
      of Delaware, in the form of Exhibit A attached hereto.

            "Closing"  means  the  closing  of  the  purchase  and  sale  of the
      Securities pursuant to Section 2.1.

            "Closing  Date" means the  Trading  Day when all of the  Transaction
      Documents  have been  executed  and  delivered by the  applicable  parties
      thereto, and all conditions precedent to (i) each Purchaser's  obligations
      to pay the Subscription  Amount have been satisfied or waived (ii) and the
      Company's  obligations  to deliver the  Securities  have been satisfied or
      waived.

            "Commission" means the Securities and Exchange Commission.

            "Common  Stock"  means the common  stock of the  Company,  par value
      $0.001 per share,  and any  securities  into which such common stock shall
      hereinafter been reclassified into.

            "Common Stock  Equivalents"  means any  securities of the Company or
      the Subsidiaries  which would entitle the holder thereof to acquire at any
      time Common  Stock,  including  without  limitation,  any debt,  preferred
      stock, rights,  options,  warrants or other instrument that is at any time
      convertible  into or  exchangeable  for, or otherwise  entitles the holder
      thereof to receive, Common Stock.

            "Company Counsel" means Sichenzia Ross Friedman Ference LLP.

            "Disclosure Schedules" means the Disclosure Schedules of the Company
      delivered concurrently herewith.

            "Discussion Time" shall mean 9 P.M. (New York Time) on such calendar
      day when the Purchaser was first contacted  regarding an investment in the
      Company.

            "Effective Date" means the date that the  Registration  Statement is
      first declared effective by the Commission.

            "Exchange  Act"  means  the  Securities  Exchange  Act of  1934,  as
      amended.

            "Exempt  Issuance"  the  issuance  of (a) shares of Common  Stock or
      options to employees, officers or directors of the Company pursuant to any
      stock or option plan duly adopted (b)  securities  upon the exercise of or
      conversion of any securities  issued  hereunder,  convertible  securities,
      options or warrants  issued and outstanding on the date of this Agreement,
      provided that such securities have not been amended since the date of this
      Agreement to increase the number of such securities.

            "GAAP"  shall  have the  meaning  ascribed  to such term in  Section
      3.1(h).

                                       2
<PAGE>

            "Liens" means a lien, charge, security interest,  encumbrance, right
      of first refusal, preemptive right or other restriction.

            "Losses"  means any and all losses,  claims,  damages,  liabilities,
      settlement  costs and  expenses,  including  without  limitation  costs of
      preparation and reasonable attorneys' fees.

            "Majority in Interest" shall mean, at any time of determination, the
      majority in interest  (based on  then-outstanding  Stated Value amounts of
      Preferred Stock at the time of such determination) of the Purchasers.

            "Market  Price"  shall mean the average of the 10 VWAPs  immediately
      prior to the date in question.

            "Material  Adverse  Effect" shall have the meaning  assigned to such
      term in Section 3.1(b).

            "Material  Permits" shall have the meaning  ascribed to such term in
      Section 3.1(m).

            "Person"  means an individual or  corporation,  partnership,  trust,
      incorporated  or  unincorporated   association,   joint  venture,  limited
      liability  company,  joint  stock  company,  government  (or an  agency or
      subdivision thereof) or other entity of any kind.

            "Preferred  Stock"  means the up to 30,000  shares of the  Company's
      Series A Convertible  Preferred Stock issued  hereunder having the rights,
      preferences and privileges set forth in the Certificate of Designation.

            "Proceeding"  means  an  action,   claim,  suit,   investigation  or
      proceeding  (including,  without  limitation,  an investigation or partial
      proceeding, such as a deposition), whether commenced or threatened.

            "Registration   Rights  Agreement"  means  the  Registration  Rights
      Agreement, dated the date hereof, among the Company and each Purchaser, in
      the form of Exhibit B.

            "Registration  Statement" means a registration statement meeting the
      requirements set forth in the  Registration  Rights Agreement and covering
      the resale by the Purchasers of the Underlying Shares.

            "Required Approvals" shall have the meaning ascribed to such term in
      Section 3.1(e).

            "Rule 144" means Rule 144 promulgated by the Commission  pursuant to
      the Securities  Act, as such Rule may be amended from time to time, or any
      similar rule or  regulation  hereafter  adopted by the  Commission  having
      substantially the same effect as such Rule.

                                       3
<PAGE>

            "SEC  Reports"  shall  have the  meaning  ascribed  to such  term in
      Section 3.1(h).

            "Securities"  means  the  Preferred  Stock,  the  Warrants  and  the
      Underlying Shares.

            "Securities Act" means the Securities Act of 1933, as amended.

            "Set  Price"  shall have the  meaning  ascribed  to such term in the
      Certificate of Designations.

            "Shareholder Approval" means such approval as may be required by the
      applicable  rules and  regulations of the Trading Market (or any successor
      entity)  from  the  shareholders  of  the  Company  with  respect  to  the
      transactions  contemplated  by the  Transaction  Documents,  including the
      issuance  of all of the  Underlying  Shares  and  shares of  Common  Stock
      issuable upon exercise of the Warrants in excess of 19.9% of the Company's
      issued and outstanding Common Stock on the Closing Date.

            "Short Sales" shall include,  without limitation,  all "short sales"
      as defined in Rule 3b-3 of the Exchange Act.

            "Stated Value" means $100 per share of Preferred Stock.

            "Subscription  Amount" shall mean, as to each Purchaser,  the amount
      to be paid for the Preferred Stock purchased  hereunder as specified below
      such Purchaser's  name on the signature page of this Agreement,  in United
      States Dollars.

            "Subsidiary" means any subsidiary of the Company that is required to
      be listed in Schedule 3.1(a).

            "Trading Day" means any day during which the Trading Market shall be
      open for business.

            "Trading  Market" means the following  markets or exchanges on which
      the Common  Stock is listed or quoted for trading on the date in question:
      OTC  Bulletin  Board,  the  American  Stock  Exchange,  the New York Stock
      Exchange, the Nasdaq National Market or the Nasdaq SmallCap Market.

            "Transaction  Documents"  means this  Agreement,  the Certificate of
      Designation, the Warrants, the Registration Rights Agreement and any other
      documents  or  agreements  executed in  connection  with the  transactions
      contemplated hereunder.

            "Underlying  Shares" means the shares of Common Stock  issuable upon
      conversion  of the  Preferred  Stock,  upon  exercise of the  Warrants and
      issued  and  issuable  in lieu of the cash  payment  of  dividends  on the
      Preferred Stock.

            "VWAP" means, for any date, the price determined by the first of the
      following clauses that applies:  (a) if the Common Stock is then listed or
      quoted on a Trading Market, the daily volume weighted average price of the
      Common Stock for such date (or the nearest  preceding date) on the Trading
      Market on which the Common  Stock is then  listed or quoted as reported by
      Bloomberg  Financial L.P.  (based on a Trading Day from 9:30 a.m.  Eastern
      Time to 4:02  p.m.  Eastern  Time);  (b) if the  Common  Stock is not then
      listed or quoted on a Trading  Market and if prices  for the Common  Stock
      are then quoted on the OTC Bulletin  Board,  the volume  weighted  average
      price of the Common Stock for such date (or the nearest preceding date) on
      the OTC  Bulletin  Board;  (c) if the Common  Stock is not then  listed or
      quoted on the OTC  Bulletin  Board and if prices for the Common  Stock are
      then  reported in the "Pink  Sheets"  published by the National  Quotation
      Bureau Incorporated (or a similar organization or agency succeeding to its
      functions of reporting prices), the most recent bid price per share of the
      Common Stock so reported; or (c) in all other cases, the fair market value
      of a share of  Common  Stock as  determined  by an  independent  appraiser
      selected in good faith by the Purchasers and reasonably  acceptable to the
      Company.

                                       4
<PAGE>

            "Warrants" means the Common Stock Purchase Warrants,  in the form of
      Exhibit C, delivered to the  Purchasers at the Closing in accordance  with
      Section 2.2 hereof,  which warrants shall be exercisable  immediately upon
      issuance for a term of 3 years

            "Warrant  Shares"  means the shares of Common  Stock  issuable  upon
      exercise of the Warrants.

                                   ARTICLE II
                                PURCHASE AND SALE

      2.1 Closing.  On the Closing Date,  each Purchaser shall purchase from the
Company,  severally and not jointly with the other  Purchasers,  and the Company
shall issue and sell to each  Purchaser,  (a) shares of Preferred  Stock with an
aggregate Stated Value equal to such Purchaser's  Subscription  Amount;  and (b)
the Warrants as determined  pursuant to Section 2.2(a).  The aggregate number of
shares of Preferred Stock sold hereunder shall be up to 30,000.

      Upon  satisfaction of the conditions set forth in Section 2.2, the Closing
shall occur at the offices of Sichenzia Ross Friedman  Ference LLP or such other
location as the parties shall mutually agree.

      2.2 Conditions to Closing.  The Closing is subject to the  satisfaction or
waiver by the party to be benefited thereby of the following conditions:

            (a) The Company  shall have  delivered  or caused to be delivered to
      each Purchaser the following:

                  (i) this Agreement duly executed by the Company;

                  (ii) a certificate  evidencing a number of shares of Preferred
            Stock equal to such Purchaser's  Subscription Amount divided by 100,
            registered in the name of such Purchaser;

                                       5
<PAGE>

                  (iii) a Warrant  registered  in the name of such  Purchaser to
            purchase  up to a number of shares  of  Common  Stock  equal to such
            Purchaser's  Subscription  Amount divided by 100 and then multiplied
            by 1,000, with an exercise price equal $0.10 per share;

                  (iv) a Warrant  registered  in the name of such  Purchaser  to
            purchase  up to a number of shares  of  Common  Stock  equal to such
            Purchaser's  Subscription  Amount divided by 100 and then multiplied
            by 1,000, with an exercise price equal $0.125 per share

                  (v) the  Registration  Rights  Agreement  duly executed by the
            Company; and

                  (vi) the Escrow Agreement duly executed by the Company; and

                  (vii) a legal  opinion  of  Company  Counsel,  in the  form of
            Exhibit D attached hereto, addressed to each Purchaser.

            (b) At the Closing, each Purchaser shall have delivered or caused to
      be delivered to the Company the following:

                  (i) this Agreement duly executed by such Purchaser;

                  (ii) the Escrow Agreement duly executed by such Purchaser;

                  (iii) such Purchaser's Subscription Amount by wire transfer to
            the account as specified in writing by the Company; and

                  (iv) the  Registration  Rights Agreement duly executed by such
            Purchaser.

            (c) All  representations and warranties of the other party contained
      herein  shall  remain  true and  correct  as of the  Closing  Date and all
      covenants  of the other  party shall have been  performed  if due prior to
      such date.

            (d) From the date hereof to the Closing Date,  trading in the Common
      Stock  shall not have been  suspended  by the  Commission  (except for any
      suspension of trading of limited duration agreed to by the Company,  which
      suspension  shall be terminated  prior to the  Closing),  and, at any time
      prior to the Closing Date, trading in securities  generally as reported by
      Bloomberg  Financial Markets shall not have been suspended or limited,  or
      minimum prices shall not have been  established on securities whose trades
      are  reported  by such  service,  or on any  Trading  Market,  nor shall a
      banking  moratorium  have been declared either by the United States or New
      York State authorities nor shall there have occurred any material outbreak
      or escalation of hostilities or other national or  international  calamity
      of such magnitude in its effect on, or any material adverse change in, any
      financial  market which, in each case, in the reasonable  judgment of each
      Purchaser, makes it impracticable or inadvisable to purchase the shares of
      Preferred Stock at the Closing.

                                       6
<PAGE>

                                   ARTICLE III
                         REPRESENTATIONS AND WARRANTIES

      3.1 Representations and Warranties of the Company.  Except as set forth in
the SEC Reports or under the corresponding  section of the Disclosure  Schedules
which  Disclosure  Schedules  shall be deemed a part hereof , the Company hereby
makes the representations and warranties set forth below to each Purchaser:

            (a) Subsidiaries. All of the direct and indirect subsidiaries of the
      Company are set forth on Schedule  3.1(a).  The Company owns,  directly or
      indirectly,  all of the capital  stock or other  equity  interests of each
      Subsidiary free and clear of any Liens, and all the issued and outstanding
      shares of capital  stock of each  Subsidiary  are  validly  issued and are
      fully paid,  non-assessable  and free of preemptive  and similar rights to
      subscribe for or purchase securities.  If the Company has no subsidiaries,
      then references in the Transaction  Documents to the Subsidiaries  will be
      disregarded.

            (b)  Organization  and  Qualification.  Each of the  Company and the
      Subsidiaries  is an  entity  duly  incorporated  or  otherwise  organized,
      validly  existing and in good standing under the laws of the  jurisdiction
      of its  incorporation or organization (as applicable),  with the requisite
      power and authority to own and use its  properties and assets and to carry
      on its  business  as  currently  conducted.  Neither  the  Company nor any
      Subsidiary  is in  violation  or default of any of the  provisions  of its
      respective  certificate  or  articles  of  incorporation,  bylaws or other
      organizational  or  charter  documents.   Each  of  the  Company  and  the
      Subsidiaries is duly qualified to conduct business and is in good standing
      as a foreign corporation or other entity in each jurisdiction in which the
      nature  of the  business  conducted  or  property  owned by it makes  such
      qualification necessary, except where the failure to be so qualified or in
      good  standing,  as the  case may be,  could  not  have or  reasonably  be
      expected  to  result in (i) a  material  adverse  effect on the  legality,
      validity or  enforceability of any Transaction  Document,  (ii) a material
      adverse effect on the results of operations,  assets, business,  prospects
      or  financial  condition of the Company and the  Subsidiaries,  taken as a
      whole,  or (iii) a material  adverse  effect on the  Company's  ability to
      perform in any material  respect on a timely basis its  obligations  under
      any Transaction  Document (any of (i), (ii) or (iii), a "Material  Adverse
      Effect") and no Proceeding  has been  instituted in any such  jurisdiction
      revoking,  limiting or curtailing  or seeking to revoke,  limit or curtail
      such power and authority or qualification.

            (c)  Authorization;  Enforcement.  The  Company  has  the  requisite
      corporate  power  and  authority  to  enter  into  and to  consummate  the
      transactions  contemplated  by  each  of  the  Transaction  Documents  and
      otherwise  to carry  out its  obligations  hereunder  or  thereunder.  The
      execution and delivery of each of the Transaction Documents by the Company
      and the  consummation  by it of the  transactions  contemplated  hereby or
      thereby have been duly  authorized by all necessary  action on the part of
      the  Company  and no further  consent or action is required by the Company
      other than Required Approvals.  Each of the Transaction Documents has been
      (or  upon  delivery  will be)  duly  executed  by the  Company  and,  when
      delivered in accordance  with the terms hereof,  will constitute the valid
      and binding obligation of the Company  enforceable  against the Company in
      accordance with its terms, subject to applicable  bankruptcy,  insolvency,
      fraudulent  conveyance,   reorganization,   moratorium  and  similar  laws
      affecting  creditors' rights and remedies generally and general principles
      of equity.  Neither the Company nor any  Subsidiary is in violation of any
      of  the   provisions  of  its   respective   certificate  or  articles  of
      incorporation, by-laws or other organizational or charter documents except
      where  such  violation  could  not,  individually  or  in  the  aggregate,
      constitute a Material Adverse Effect.

                                       7
<PAGE>

            (d) Issuance of the  Securities.  The Securities are duly authorized
      and,  when  issued  and  paid  for  in  accordance   with  the  applicable
      Transaction  Documents,  will be duly and validly  issued,  fully paid and
      nonassessable,  free and clear of all Liens. The Company has reserved from
      its duly  authorized  capital stock a number of shares of Common Stock for
      issuance of the Underlying  Shares at least equal to the Actual Minimum on
      the date hereof.

            (e)  Capitalization.   The  capitalization  of  the  Company  is  as
      described  in the  Company's  most recent  periodic  report filed with the
      Commission. The Company has not issued any capital stock since such filing
      other than  pursuant to the exercise of employee  stock  options under the
      Company's  stock option  plans,  the issuance of shares of Common Stock to
      employees  pursuant to the  Company's  employee  stock  purchase  plan and
      pursuant  to the  conversion  or  exercise  of  outstanding  Common  Stock
      Equivalents. No further approval or authorization of any stockholder,  the
      Board of  Directors  of the Company or others is required for the issuance
      and sale of the shares of Preferred Stock.  Except as disclosed in the SEC
      Reports, there are no stockholders agreements,  voting agreements or other
      similar  agreements  with respect to the Company's  capital stock to which
      the Company is a party or, to the  knowledge  of the  Company,  between or
      among any of the Company's stockholders.

            (f) SEC  Reports;  Financial  Statements.  The Company has filed all
      reports  required  to be  filed  by it under  the  Securities  Act and the
      Exchange Act,  including  pursuant to Section 13(a) or 15(d) thereof,  for
      the two years  preceding  the date hereof (or such  shorter  period as the
      Company  was  required  by law  to  file  such  material)  (the  foregoing
      materials,  including the exhibits thereto, being collectively referred to
      herein as the "SEC  Reports")  on a timely  basis or has  received a valid
      extension of such time of filing and has filed any such SEC Reports  prior
      to the expiration of any such extension. As of their respective dates, the
      SEC Reports complied in all material respects with the requirements of the
      Securities  Act and the Exchange Act and the rules and  regulations of the
      Commission  promulgated  thereunder,  and  none of the SEC  Reports,  when
      filed,  contained  any untrue  statement of a material  fact or omitted to
      state a material fact required to be stated  therein or necessary in order
      to make the statements  therein, in light of the circumstances under which
      they were made, not  misleading.  The financial  statements of the Company
      included  in  the  SEC  Reports  comply  in  all  material  respects  with
      applicable  accounting  requirements  and the rules and regulations of the
      Commission with respect  thereto as in effect at the time of filing.  Such
      financial  statements  have been prepared in accordance with United States
      generally  accepted  accounting  principles  applied on a consistent basis
      during the periods involved ("GAAP"), except as may be otherwise specified
      in such  financial  statements  or the notes ----  thereto and except that
      unaudited  financial  statements may not contain all footnotes required by
      GAAP, and fairly present in all material  respects the financial  position
      of the Company and its  consolidated  subsidiaries as of and for the dates
      thereof and the results of operations  and cash flows for the periods then
      ended,  subject,  in  the  case  of  unaudited   statements,   to  normal,
      immaterial, year-end audit adjustments.

                                       8
<PAGE>

            (g) Material Changes. Since the date of the latest audited financial
      statements  included  within  the  SEC  Reports,  except  as  specifically
      disclosed in the SEC Reports,  (i) there has been no event,  occurrence or
      development that has had or that could reasonably be expected to result in
      a  Material  Adverse  Effect,  (ii)  the  Company  has  not  incurred  any
      liabilities  (contingent  or otherwise)  other than (A) trade payables and
      accrued  expenses  incurred in the ordinary course of business  consistent
      with past practice and (B) liabilities not required to be reflected in the
      Company's  financial  statements  pursuant  to  GAAP  or  required  to  be
      disclosed in filings made with the  Commission,  (iii) the Company has not
      altered its method of  accounting,  (iv) the  Company has not  declared or
      made  any  dividend  or  distribution  of cash or  other  property  to its
      stockholders or purchased,  redeemed or made any agreements to purchase or
      redeem any shares of its capital  stock and (v) the Company has not issued
      any equity  securities  to any  officer,  director  or  Affiliate,  except
      pursuant to existing Company stock option plans. The Company does not have
      pending before the Commission  any request for  confidential  treatment of
      information.

            (h)  Litigation.  There  is no  action,  suit,  inquiry,  notice  of
      violation, proceeding or investigation pending or, to the knowledge of the
      Company,  threatened  against or affecting the Company,  any Subsidiary or
      any of their  respective  properties  before or by any court,  arbitrator,
      governmental or administrative  agency or regulatory  authority  (federal,
      state,  county,  local or foreign)  (collectively,  an "Action") which (i)
      adversely  affects or challenges the legality,  validity or enforceability
      of any of the  Transaction  Documents or the Securities or (ii) could,  if
      there were an  unfavorable  decision,  have or  reasonably  be expected to
      result  in  a  Material  Adverse  Effect.  Neither  the  Company  nor  any
      Subsidiary,  nor any  director  or  officer  thereof,  is or has  been the
      subject of any Action involving a claim of violation of or liability under
      federal or state  securities  laws or a claim of breach of fiduciary duty.
      There has not been,  and to the  knowledge  of the  Company,  there is not
      pending or contemplated, any investigation by the Commission involving the
      Company or any current or former  director or officer of the Company.  The
      Commission  has not issued any stop order or other  order  suspending  the
      effectiveness  of any  registration  statement filed by the Company or any
      Subsidiary under the Exchange Act or the Securities Act.

            (i) Labor  Relations.  No material  labor dispute  exists or, to the
      knowledge of the Company, is imminent with respect to any of the employees
      of the Company which could  reasonably be expected to result in a Material
      Adverse Effect.

                                       9
<PAGE>

            (j) Regulatory Permits. The Company and the Subsidiaries possess all
      certificates,   authorizations  and  permits  issued  by  the  appropriate
      federal,  state,  local or foreign  regulatory  authorities  necessary  to
      conduct  their  respective  businesses  as  described  in the SEC Reports,
      except where the failure to possess such permits  could not,  individually
      or in the  aggregate,  have or  reasonably  be  expected  to  result  in a
      Material Adverse Effect ("Material Permits"),  and neither the Company nor
      any  Subsidiary  has  received any notice of  proceedings  relating to the
      revocation or modification of any Material Permit.

            (k) Title to Assets.  The Company and the Subsidiaries have good and
      marketable  title in fee simple to all real property owned by them that is
      material to the business of the Company and the  Subsidiaries and good and
      marketable  title in all personal  property owned by them that is material
      to the business of the Company and the Subsidiaries, in each case free and
      clear of all Liens, except for Liens as do not materially affect the value
      of such  property and do not  materially  interfere  with the use made and
      proposed to be made of such  property by the Company and the  Subsidiaries
      and Liens for the payment of federal, state or other taxes, the payment of
      which is neither  delinquent  nor subject to penalties.  Any real property
      and facilities  held under lease by the Company and the  Subsidiaries  are
      held by them under valid,  subsisting and enforceable  leases of which the
      Company and the Subsidiaries are in compliance.

            (l) Patents and Trademarks.  The Company and the Subsidiaries  have,
      or have  rights to use,  all  patents,  patent  applications,  trademarks,
      trademark applications,  service marks, trade names, copyrights,  licenses
      and  other  similar  rights  that are  necessary  or  material  for use in
      connection  with  their  respective  businesses  as  described  in the SEC
      Reports  and which the  failure to so have  could have a Material  Adverse
      Effect  (collectively,  the "Intellectual  Property Rights").  Neither the
      Company  nor any  Subsidiary  has  received  a  written  notice  that  the
      Intellectual  Property  Rights  used  by the  Company  or  any  Subsidiary
      violates or infringes  upon the rights of any Person.  To the knowledge of
      the Company,  all such  Intellectual  Property  Rights are enforceable and
      there  is no  existing  infringement  by  another  Person  of  any  of the
      Intellectual Property Rights of others.

            (m) Transactions With Affiliates and Employees.  Except as set forth
      in the SEC Reports,  none of the officers or directors of the Company and,
      to the  knowledge of the Company,  none of the employees of the Company is
      presently a party to any  transaction  with the Company or any  Subsidiary
      (other than for services as employees, officers and directors),  including
      any contract,  agreement or other arrangement providing for the furnishing
      of services to or by, providing for rental of real or personal property to
      or from, or otherwise requiring payments to or from any officer,  director
      or such employee or, to the knowledge of the Company,  any entity in which
      any officer,  director, or any such employee has a substantial interest or
      is an officer,  director,  trustee or  partner,  in each case in excess of
      $200,000  other  than (i) for  payment  of salary or  consulting  fees for
      services  rendered,  (ii) reimbursement for expenses incurred on behalf of
      the Company and (iii) for other employee benefits,  including stock option
      agreements under any stock option plan of the Company.

                                       10
<PAGE>

            (n) Private  Placement.  Assuming  the  accuracy  of the  Purchasers
      representations  and warranties set forth in Section 3.2, no  registration
      under  the  Securities  Act is  required  for the  offer  and  sale of the
      Securities by the Company to the Purchasers as  contemplated  hereby.  The
      issuance and sale of the  Securities  hereunder  does not  contravene  the
      rules and regulations of the Trading Market.

            (o) Investment Company.  The Company is not, and is not an Affiliate
      of, and  immediately  after receipt of payment for the shares of Preferred
      Stock,  will not be or be an Affiliate of, an "investment  company" within
      the meaning of the Investment Company Act of 1940, as amended. The Company
      shall conduct its business in a manner so that it will not become  subject
      to the Investment Company Act.

            (p) Listing and Maintenance Requirements. The Company's Common Stock
      is  registered  pursuant to Section  12(g) of the  Exchange  Act,  and the
      Company  has taken no action  designed  to, or which to its  knowledge  is
      likely to have the effect of,  terminating the  registration of the Common
      Stock under the Exchange Act nor has the Company received any notification
      that the Commission is contemplating  terminating such  registration.  The
      Company  has not, in the 12 months  preceding  the date  hereof,  received
      notice  from any Trading  Market on which the Common  Stock is or has been
      listed or quoted to the effect that the Company is not in compliance  with
      the  listing or  maintenance  requirements  of such  Trading  Market.  The
      Company  is,  and  has no  reason  to  believe  that  it  will  not in the
      foreseeable future continue to be, in compliance with all such listing and
      maintenance requirements.

            (q) Disclosure.  The Company confirms that,  neither the Company nor
      any other Person  acting on its behalf has provided any of the  Purchasers
      or their agents or counsel with any information  that constitutes or might
      constitute material,  non-public information.  The Company understands and
      confirms that the  Purchasers  will rely on the foregoing  representations
      and covenants in effecting  transactions in securities of the Company. All
      disclosure provided to the Purchasers  regarding the Company, its business
      and the transactions  contemplated hereby, including the Schedules to this
      Agreement,  furnished  by or on behalf of the Company  with respect to the
      representations  and  warranties  made  herein are true and  correct  with
      respect to such  representations  and  warranties  and do not  contain any
      untrue  statement of a material  fact or omit to state any  material  fact
      necessary in order to make the  statements  made therein,  in light of the
      circumstances  under  which they were made,  not  misleading.  The Company
      acknowledges   and  agrees  that  no  Purchaser  makes  or  has  made  any
      representations   or   warranties   with   respect  to  the   transactions
      contemplated hereby other than those specifically set forth in Section 3.2
      hereof.

            (r) No  Integrated  Offering.  Neither the  Company,  nor any of its
      Affiliates,  nor any Person acting on its or their behalf has, directly or
      indirectly,  made any offers or sales of any  security  or  solicited  any
      offers to buy any  security,  under  circumstances  that would  cause this
      offering of the  Securities to be integrated  with prior  offerings by the
      Company for  purposes  of the  Securities  Act or which could  violate any
      applicable shareholder approval provisions, including, without limitation,
      under the rules and regulations of the Trading Market.

                                       11
<PAGE>

            (s) Tax Status. The Company and each of its Subsidiaries has made or
      filed all  federal,  state and foreign  income and all other tax  returns,
      reports  and  declarations  required  by any  jurisdiction  to which it is
      subject  (unless  and only to the extent  that the Company and each of its
      Subsidiaries has set aside on its books provisions reasonably adequate for
      the payment of all unpaid and unreported taxes) and has paid all taxes and
      other  governmental  assessments  and charges that are material in amount,
      shown or determined to be due on such returns,  reports and  declarations,
      except those being  contested in good faith and has set aside on its books
      provisions  reasonably  adequate  for the payment of all taxes for periods
      subsequent to the periods to which such returns,  reports or  declarations
      apply.  There are no unpaid taxes in any material amount claimed to be due
      by the taxing  authority  of any  jurisdiction,  and the  officers  of the
      Company know of no basis for any such claim.  The Company has not executed
      a waiver  with  respect to the  statute  of  limitations  relating  to the
      assessment  or collection  of any foreign,  federal,  statue or local tax.
      None of the Company's tax returns is presently being audited by any taxing
      authority.

            (t) No  General  Solicitation  or  Advertising  in  Regard  to  this
      Transaction. Neither the Company nor, to the knowledge of the Company, any
      of its directors or officers (i) has conducted or will conduct any general
      solicitation  (as that  term is used in Rule  502(c) of  Regulation  D) or
      general advertising with respect to the sale of the Preferred Stock or the
      Warrants,  or (ii) made any offers or sales of any  security or  solicited
      any offers to buy any security under any circumstances  that would require
      registration of the Preferred Stock, the Underlying Shares or the Warrants
      under the Securities Act or made any "directed selling efforts" as defined
      in Rule 902 of Regulation S.

            (u)  Foreign  Corrupt  Practices.  Neither the  Company,  nor to the
      knowledge  of the Company,  any agent or other person  acting on behalf of
      the Company,  has (i) directly or  indirectly,  used any corrupt funds for
      unlawful  contributions,  gifts,  entertainment or other unlawful expenses
      related to foreign or domestic political activity,  (ii) made any unlawful
      payment to foreign or domestic government officials or employees or to any
      foreign or domestic  political  parties or campaigns from corporate funds,
      (iii) failed to disclose  fully any  contribution  made by the Company (or
      made by any  person  acting on its  behalf of which the  Company is aware)
      which is in violation of law, or (iv) violated in any material respect any
      provision of the Foreign Corrupt Practices Act of 1977, as amended.

            (w) Acknowledgment Regarding Purchasers' Purchase of Securities. The
      Company  acknowledges  and agrees that the Purchasers are acting solely in
      the capacity of arm's length purchasers with respect to this Agreement and
      the transactions  contemplated  hereby.  The Company further  acknowledges
      that no  Purchaser  is acting as a financial  advisor or  fiduciary of the
      Company (or in any similar  capacity)  with respect to this  Agreement and
      the  transactions  contemplated  hereby  and  any  statement  made  by any
      Purchaser  or  any  of  their  respective  representatives  or  agents  in
      connection with this Agreement and the transactions contemplated hereby is
      not advice or a recommendation and is merely incidental to the Purchasers'
      purchase  of the  Securities.  The  Company  further  represents  to  each
      Purchaser  that the  Company's  decision to enter into this  Agreement has
      been based  solely on the  independent  evaluation  of the Company and its
      representatives.

                                       12
<PAGE>

      3.2  Representations  and  Warranties of the  Purchasers.  Each  Purchaser
hereby, for itself and for no other Purchaser, represents and warrants as of the
date hereof and as of the Closing Date to the Company as follows:

            (a)  Organization;  Authority.  Such  Purchaser  is an  entity  duly
      organized,  validly  existing and in good  standing  under the laws of the
      jurisdiction of its organization with full right, corporate or partnership
      power and  authority  to enter  into and to  consummate  the  transactions
      contemplated by the  Transaction  Documents and otherwise to carry out its
      obligations  thereunder.  The execution,  delivery and performance by such
      Purchaser of the  transactions  contemplated  by this  Agreement have been
      duly  authorized by all necessary  corporate or similar action on the part
      of such Purchaser.  Each  Transaction  Document to which it is a party has
      been duly executed by such Purchaser, and when delivered by such Purchaser
      in accordance with the terms hereof, will constitute the valid and legally
      binding obligation of such Purchaser, enforceable against it in accordance
      with its terms, except (i) as limited by general equitable  principles and
      applicable bankruptcy,  insolvency,  reorganization,  moratorium and other
      laws of general  application  affecting  enforcement of creditors'  rights
      generally,  (ii)  as  limited  by laws  relating  to the  availability  of
      specific  performance,  injunctive relief or other equitable  remedies and
      (iii)  insofar  as  indemnification  and  contribution  provisions  may be
      limited by applicable law.

            (b) No View to  Distribute.  Such  Purchaser  understands  that  the
      Securities are "restricted  securities" and have not been registered under
      the Securities Act or any applicable state securities law and is acquiring
      the  Securities as principal for its own account and not with a view to or
      for distributing or reselling such Securities or any part thereof,  has no
      present  intention  of  distributing  any of  such  Securities  and has no
      arrangement  or  understanding   with  any  other  persons  regarding  the
      distribution  of such  Securities  (this  representation  and warranty not
      limiting such  Purchaser's  right to sell the  Securities  pursuant to the
      Registration  Statement or otherwise in compliance with applicable federal
      and state  securities  laws).  Such  Purchaser is acquiring the Securities
      hereunder in the ordinary course of its business.  Such Purchaser does not
      have any  agreement or  understanding,  directly or  indirectly,  with any
      Person to distribute any of the Securities.

            (c)  Purchaser  Status.  At the time such  Purchaser was offered the
      Securities,  it was,  and at the date  hereof  it is,  and on each date on
      which it exercises any  Warrants,  it will be either:  (i) an  "accredited
      investor" as defined in Rule 501(a)(1),  (a)(2),  (a)(3), (a)(7) or (a)(8)
      under the  Securities  Act or (ii) a  "qualified  institutional  buyer" as
      defined in Rule 144A(a) under the  Securities  Act. Such  Purchaser is not
      required  to be  registered  as a  broker-dealer  under  Section 15 of the
      Exchange Act.

                                       13
<PAGE>

            (d) Experience of Such Purchaser.  Such  Purchaser,  either alone or
      together with its representatives,  has such knowledge, sophistication and
      experience  in  business  and  financial  matters  so as to be  capable of
      evaluating  the  merits  and risks of the  prospective  investment  in the
      Securities,  and has so evaluated the merits and risks of such investment.
      Such  Purchaser is able to bear the economic  risk of an investment in the
      Securities  and, at the present time, is able to afford a complete loss of
      such investment.

            (e) General  Solicitation.  Such  Purchaser  is not  purchasing  the
      Securities  as a result  of any  advertisement,  article,  notice or other
      communication   regarding  the  Securities  published  in  any  newspaper,
      magazine  or  similar  media  or  broadcast  over  television  or radio or
      presented  at any  seminar or any other  general  solicitation  or general
      advertisement.

            (f) Short Sales.  Each  Purchaser  covenants that neither it nor any
      affiliates acting on its behalf or pursuant to any  understanding  with it
      will  execute any Short Sales during the period from the  Discussion  Time
      until  prior  to the  time  that  the  transactions  contemplated  by this
      Agreement  are first  publicly  announced  as  described  in Section  4.7.
      Notwithstanding  the  foregoing,  no Purchaser  makes any  representation,
      warranty or covenant  hereby that it will not engage in Short Sales in the
      securities   of  the  Company   after  the  time  that  the   transactions
      contemplated  by this Agreement are first publicly  announced as described
      in Section 4.7.

            (g) Risk Factors. Each Purchaser represents and warrants that it has
      read and understands the attached Risk Factors relating to the Company

      The Company  acknowledges  and agrees that each Purchaser does not make or
has not made any  representations or warranties with respect to the transactions
contemplated hereby other than those specifically set forth in this Section 3.2.

                                   ARTICLE IV
                         OTHER AGREEMENTS OF THE PARTIES

      4.1 Transfer Restrictions.

            (a) The Securities may only be disposed of in compliance  with state
      and federal securities laws. In connection with any transfer of Securities
      other than pursuant to an effective registration statement or Rule 144, to
      the Company or to an  Affiliate  of a Purchaser  or in  connection  with a
      pledge as  contemplated  in Section  4.1(b),  the  Company may require the
      transferor  thereof  to  provide  to the  Company  an  opinion  of counsel
      selected by the transferor and reasonably  acceptable to the Company,  the
      form and substance of which  opinion and shall be reasonably  satisfactory
      to the  Company,  to the  effect  that  such  transfer  does  not  require
      registration of such transferred Securities under the Securities Act. As a
      condition of transfer,  any such  transferee  shall agree in writing to be
      bound by the  terms of this  Agreement  and  shall  have the  rights  of a
      Purchaser under this Agreement and the Registration Rights Agreement.

                                       14
<PAGE>

            (b) Each Purchaser agrees to the imprinting,  so long as is required
      by  this  Section  4.1(b),  of the  following  legend  on any  certificate
      evidencing Securities:

      [NEITHER] THESE SECURITIES [NOR THE SECURITIES INTO WHICH THESE SECURITIES
      ARE [EXERCISABLE]  [CONVERTIBLE]] HAVE BEEN REGISTERED WITH THE SECURITIES
      AND  EXCHANGE  COMMISSION  OR THE  SECURITIES  COMMISSION  OF ANY STATE IN
      RELIANCE UPON AN EXEMPTION FROM  REGISTRATION  UNDER THE SECURITIES ACT OF
      1933, AS AMENDED (THE  "SECURITIES  ACT"),  AND,  ACCORDINGLY,  MAY NOT BE
      OFFERED OR SOLD EXCEPT  PURSUANT TO AN  EFFECTIVE  REGISTRATION  STATEMENT
      UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN
      A  TRANSACTION  NOT  SUBJECT  TO,  THE  REGISTRATION  REQUIREMENTS  OF THE
      SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE  STATE SECURITIES LAWS AS
      EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE  TRANSFEROR TO SUCH EFFECT,
      THE  SUBSTANCE  OF WHICH SHALL BE  REASONABLY  ACCEPTABLE  TO THE COMPANY.
      THESE  SECURITIES  AND THE  SECURITIES  ISSUABLE  UPON  EXERCISE  OF THESE
      SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR
      OTHER LOAN SECURED BY SUCH SECURITIES.

            The Company  acknowledges  and agrees that a Purchaser may from time
      to time pledge pursuant to a bona fide margin  agreement with a registered
      broker-dealer  or  grant  a  security  interest  in  some  or  all  of the
      Securities to a financial  institution that is an "accredited investor" as
      defined in Rule 501(a) under the Securities Act and who agrees to be bound
      by the provisions of this Agreement and the Registration  Rights Agreement
      and, if required under the terms of such  arrangement,  such Purchaser may
      transfer pledged or secured Securities to the pledgees or secured parties.
      Such a pledge or transfer  would not be subject to approval of the Company
      and no legal  opinion of legal  counsel of the pledgee,  secured  party or
      pledgor  shall be required in  connection  therewith.  Further,  no notice
      shall be required of such pledge. At the appropriate  Purchaser's expense,
      the Company will execute and deliver such  reasonable  documentation  as a
      pledgee  or  secured  party  of  Securities  may  reasonably   request  in
      connection with a pledge or transfer of the Securities,  including, if the
      Securities are subject to registration pursuant to the Registration Rights
      Agreement,   the  preparation  and  filing  of  any  required   prospectus
      supplement  under  Rule  424(b)(3)  under  the  Securities  Act  or  other
      applicable provision of the Securities Act to appropriately amend the list
      of Selling Stockholders thereunder.

                                       15
<PAGE>

            (c) Certificates  evidencing Underlying Shares shall not contain any
      legend  (including  the legend set forth in Section  4.1(b)):  (i) while a
      registration statement (including the Registration Statement) covering the
      resale of such Underlying Shares is effective under the Securities Act, or
      (ii) following any sale of such Underlying Shares pursuant to Rule 144, or
      (iii) if such Securities are eligible for sale under Rule 144(k),  or (iv)
      if such  legend  is not  required  under  applicable  requirements  of the
      Securities  Act (including  judicial  interpretations  and  pronouncements
      issued  by the  Staff of the  Commission).  The  Company  shall  cause its
      counsel to issue a legal opinion to the Company's  transfer agent promptly
      after the Effective  Date if required by the Company's  transfer  agent to
      effect  the  removal  of the  legend  hereunder.  If all or any  shares of
      Preferred  Stock or any portion of a Warrant is converted or exercised (as
      applicable) at a time when there is an effective registration statement to
      cover the resale of the Underlying  Shares,  or if such Underlying  Shares
      may be sold under Rule 144(k) or if such legend is not otherwise  required
      under  applicable  requirements of the Securities Act (including  judicial
      interpretations  thereof) then such Underlying Shares shall be issued free
      of all legends. The Company agrees that following the Effective Date or at
      such time as such legend is no longer  required under this Section 4.1(c),
      it will,  no later than three  Trading  Days  following  the delivery by a
      Purchaser to the Company or the Company's  transfer agent of a certificate
      representing  Securities issued with a restrictive  legend (such date, the
      "Legend Removal Date"), deliver or cause to be delivered to such Purchaser
      a certificate  representing  such Underlying  Shares that is free from all
      restrictive  and other  legends.  The Company may not make any notation on
      its records or give instructions to any transfer agent of the Company that
      enlarge  the   restrictions   on  transfer  set  forth  in  this  Section.
      Certificates for Securities  subject to legend removal  hereunder shall be
      transmitted  by the  transfer  agent of the Company to the  Purchasers  by
      crediting the account of the Purchaser's  prime broker with the Depository
      Trust Company System.

            (d) In addition to such Purchaser's  other available  remedies,  the
      Company shall pay to a Purchaser,  in cash, as partial  liquidated damages
      and not as a penalty, for each $100,000 of Underlying Shares (based on the
      VWAP on the date such  Securities are submitted to the Company's  transfer
      agent) delivered for removal of the restrictive legend and subject to this
      Section  4.1(c),  $10 per Trading Day  (increasing  to $20 per Trading Day
      five (5) Trading  Days after such  damages  have begun to accrue) for each
      Trading  Day after the  Legend  Removal  Date until  such  certificate  is
      delivered.  Nothing  herein shall limit such  Purchaser's  right to pursue
      actual  damages  for  the  Company's   failure  to  deliver   certificates
      representing any Securities as required by the Transaction Documents,  and
      such Purchaser shall have the right to pursue all remedies available to it
      at law or in equity including,  without  limitation,  a decree of specific
      performance and/or injunctive relief.

            (e)  Each  Purchaser,  severally  and not  jointly  with  the  other
      Purchasers,  agrees  that  the  removal  of the  restrictive  legend  from
      certificates  representing  Securities as set forth in this Section 4.1 is
      predicated  upon the Company's  reliance that the Purchaser  will sell any
      Securities  pursuant  to  either  the  registration  requirements  of  the
      Securities Act, including any applicable prospectus delivery requirements,
      or an exemption therefrom.

                                       16
<PAGE>

      4.2 Furnishing of Information.  As long as any Purchaser owns  Securities,
the Company  covenants to timely file (or obtain  extensions in respect  thereof
and file within the applicable grace period) all reports required to be filed by
the Company after the date hereof pursuant to the Exchange Act. Upon the request
of any  Purchaser,  the  Company  shall  deliver  to such  Purchaser  a  written
certification  of a duly  authorized  officer as to whether it has complied with
the preceding sentence. As long as any Purchaser owns Securities, if the Company
is not  required  to file  reports  pursuant to such laws,  it will  prepare and
furnish to each  Purchaser and make publicly  available in accordance  with Rule
144(c) such information as is required for each Purchaser to sell the Securities
under Rule 144.  The Company  further  covenants  that it will take such further
action as any holder of Securities  may  reasonably  request,  all to the extent
required from time to time to enable such Person to sell such Securities without
registration  under the  Securities  Act within the limitation of the exemptions
provided by Rule 144.

      4.3  Integration.  The Company  shall not sell,  offer for sale or solicit
offers to buy or  otherwise  negotiate in respect of any security (as defined in
Section 2 of the Securities Act) that would be integrated with the offer or sale
of the  Securities  in a manner that would  require the  registration  under the
Securities  Act of the sale of the Securities to the Purchasers or that would be
integrated  with the offer or sale of the  Securities  for purposes of the rules
and  regulations  of any Trading  Market such that it would require  shareholder
approval  prior to the  closing of such  other  transaction  unless  shareholder
approval is obtained before the closing of such subsequent transaction.

      4.4 Securities Laws Disclosure; Publicity. The Company shall, by 8:30 a.m.
Eastern time on the Trading Day following the date hereof, issue a press release
or file a Current Report on Form 8-K, in each case reasonably acceptable to each
Purchaser disclosing the material terms of the transactions contemplated hereby.
The  Company and each  Purchaser  shall  consult  with each other in issuing any
press releases with respect to the transactions contemplated hereby, and neither
the Company nor any  Purchaser  shall issue any such press  release or otherwise
make any such public  statement  without the prior consent of the Company,  with
respect to any press release of any  Purchaser,  or without the prior consent of
each Purchaser,  with respect to any press release of the Company, which consent
shall not  unreasonably  be withheld,  except if such  disclosure is required by
law, in which case the disclosing  party shall promptly  provide the other party
with prior notice of such public statement or communication. Notwithstanding the
foregoing, the Company shall not publicly disclose the name of any Purchaser, or
include  the name of any  Purchaser  in any filing  with the  Commission  or any
regulatory  agency or Trading Market,  without the prior written consent of such
Purchaser,  except (i) as required by federal  securities law in connection with
the registration statement contemplated by the Registration Rights Agreement and
(ii)  to the  extent  such  disclosure  is  required  by law or  Trading  Market
regulations,  in which case the Company shall provide the Purchasers  with prior
notice of such disclosure permitted under subclause (i) or (ii).

      4.5 Non-Public Information.  The Company covenants and agrees that neither
it nor any other Person  acting on its behalf will provide any  Purchaser or its
agents or counsel with any  information  that the Company  believes  constitutes
material non-public information,  unless prior thereto such Purchaser shall have
executed  a written  agreement  regarding  the  confidentiality  and use of such
information.  The Company  understands and confirms that each Purchaser shall be
relying on the foregoing representations in effecting transactions in securities
of the Company.

                                       17
<PAGE>

      4.6 Use of Proceeds. See Schedule 4.7.

      4.7 Reservation and Listing of Securities.

            (a) The Company  shall  maintain a reserve from its duly  authorized
      shares of Common Stock for issuance pursuant to the Transaction  Documents
      in such amount as may be required to fulfill its obligations in full under
      the Transaction Documents.

            (b) If, on any date,  the number of  authorized  but  unissued  (and
      otherwise  unreserved) shares of Common Stock is less than 130% of (i) the
      Actual  Minimum  on such  date,  minus (ii) the number of shares of Common
      Stock previously  issued pursuant to the Transaction  Documents,  then the
      Board of  Directors  of the  Company  shall  use  commercially  reasonable
      efforts to amend the Company's certificate or articles of incorporation to
      increase the number of authorized  but unissued  shares of Common Stock to
      at least the Actual  Minimum  at such time  (minus the number of shares of
      Common Stock previously issued pursuant to the Transaction Documents),  as
      soon as  possible  and in any event not later than the 75th day after such
      date;  provided  that  the  Company  will not be  required  at any time to
      authorize  a number of shares of Common  Stock  greater  than the  maximum
      remaining  number of shares of Common Stock that could  possibly be issued
      after such time pursuant to the Transaction Documents.

            (c) The Company  shall:  (i) in the time and manner  required by the
      Trading  Market,  prepare and file with such Trading  Market an additional
      shares listing application  covering a number of shares of Common Stock at
      least equal to the Actual  Minimum on the date of such  application,  (ii)
      take all steps  necessary  to cause  such  shares  of  Common  Stock to be
      approved for listing on the Trading Market as soon as possible thereafter,
      (iii) provide to each  Purchaser  evidence of such  listing,  and (iv) use
      reasonable  efforts to maintain  the listing of such Common  Stock on such
      Trading Market or another Trading Market.  In addition,  the Company shall
      hold a special  meeting of  shareholders  (which may also be at the annual
      meeting of shareholders)  at the earliest  practical date, for the purpose
      of  obtaining  Shareholder  Approval,   with  the  recommendation  of  the
      Company's  Board of  Directors  that such  proposal be  approved,  and the
      Company  shall  solicit  proxies  from  its   shareholders  in  connection
      therewith  in the same manner as all other  management  proposals  in such
      proxy statement and all management-appointed proxyholders shall vote their
      proxies in favor of such proposal.

      4.11 Conversion and Exercise Procedures.  The form of Election to Purchase
included in the  Warrants  and the forms of  Conversion  Notice  included in the
Certificate of Designation set forth the totality of the procedures  required in
order to exercise the Warrants or convert the  Preferred  Stock.  No  additional
legal opinion or other information or instructions  shall be necessary to enable
each Purchaser to exercise their Warrants or convert their Preferred  Stock. The
Company shall honor  exercises of the Warrants and  conversions of the Preferred
Stock  and  shall  deliver  Underlying  Shares  in  accordance  with the  terms,
conditions and time periods set forth in the Transaction Documents.  The Company
acknowledges  that the issuance of the  Securities may result in dilution of the
outstanding  shares of Common Stock,  which  dilution may be  substantial  under
certain market conditions. The Company further acknowledges that its obligations
under  the  Transaction  Documents,   including  its  obligation  to  issue  the
Underlying Shares pursuant to the Transaction  Documents,  are unconditional and
absolute  and not  subject  to any  right  of set  off,  counterclaim,  delay or
reduction,  regardless  of the  effect  of any such  dilution  or any  claim the
Company may have against any  Purchaser and  regardless  of the dilutive  effect
that such  issuance may have on the ownership of the other  stockholders  of the
Company.

                                       18
<PAGE>

      4.12 Future Right to  Participate.  For a period of time commencing on the
Effective Date and ending 180 calendar days  thereafter,  each  Purchaser  shall
have the right to  subscribe  for an amount of  Preferred  Stock  equaled to its
Subscription Amount on the same terms and conditions contained herein.

      4.13 Participation in Future Financing.

            From the date  hereof  until the date that is the 90 days  after the
      Effective  Date,  upon  any  financing  by  the  Company  or  any  of  its
      Subsidiaries  of Common Stock or Common Stock  Equivalents  (a "Subsequent
      Financing"),  such  Purchaser  shall have the right to  participate in the
      Subsequent  Financing in an amount  equal to up to 100% of the  Subsequent
      Financing,   subject  to  rights  of  refusal   previously   granted  (the
      "Participation Maximum").

            At least 5  Trading  Days  prior to the  closing  of the  Subsequent
      Financing, the Company shall deliver to each Purchaser a written notice of
      its  intention  to effect a  Subsequent  Financing  ("Pre-Notice"),  which
      Pre-Notice  shall ask such  Purchaser if it wants to review the details of
      such financing (such additional notice, a "Subsequent  Financing Notice").
      Upon  the  request  of a  Purchaser,  and  only  upon a  request  by  such
      Purchaser,  for a Subsequent Financing Notice, the Company shall promptly,
      but no later than 1 Trading Day after such  request,  deliver a Subsequent
      Financing Notice to such Purchaser.  The Subsequent Financing Notice shall
      describe  in  reasonable  detail  the  proposed  terms of such  Subsequent
      Financing,  the amount of proceeds intended to be raised  thereunder,  the
      Person with whom such Subsequent Financing is proposed to be effected, and
      attached  to which  shall be a term  sheet or  similar  document  relating
      thereto.

            Any Purchaser  desiring to participate in such Subsequent  Financing
      must  provide  written  notice to the  Company by not later than 5:30 p.m.
      (New York City time) on the 5th  Trading  Day after all of the  Purchasers
      have received the Pre-Notice  that the Purchaser is willing to participate
      in the Subsequent Financing, the amount of the Purchaser's  participation,
      and that the  Purchaser  has such funds ready,  willing and  available for
      investment on the terms set forth in the Subsequent  Financing  Notice. If
      the Company  receives  no notice  from a Purchaser  as of such 5th Trading
      Day, such  Purchaser  shall be deemed to have notified the Company that it
      does not elect to participate.

                                       19
<PAGE>

            If by 5:30 p.m.  (New York City time) on the 5th  Trading  Day after
      all of the Purchasers have received the Pre-Notice,  notifications  by the
      Purchasers of their willingness to participate in the Subsequent Financing
      (or to cause their  designees to participate)  is, in the aggregate,  less
      than the total amount of the  Subsequent  Financing,  then the Company may
      effect the remaining portion of such Subsequent Financing on the terms and
      to the Persons set forth in the Subsequent Financing Notice.

            If by 5:30 p.m.  (New York City time) on the 5th  Trading  Day after
      all of the Purchasers have received the Pre-Notice,  the Company  receives
      responses  to a Subsequent  Financing  Notice from  Purchasers  seeking to
      purchase more than the aggregate amount of the Participation Maximum, each
      such  Purchaser  shall have the right to purchase the greater of (a) their
      Pro Rata Portion (as defined below) of the  Participation  Maximum and (b)
      the difference between the Participation  Maximum and the aggregate amount
      of participation by all other Purchasers.  "Pro Rata Portion" is the ratio
      of (x) the Subscription Amount of Securities purchased on the Closing Date
      by a Purchaser  participating  under this  Section 4.13 and (y) the sum of
      the aggregate  Subscription Amounts of Securities purchased on the Closing
      Date by all Purchasers participating under this Section 4.13.

            The Company must  provide the  Purchasers  with a second  Subsequent
      Financing  Notice,  and the  Purchasers  will  again  have  the  right  of
      participation  set forth above in this  Section  4.13,  if the  Subsequent
      Financing  subject  to the  initial  Subsequent  Financing  Notice  is not
      consummated  for any  reason on the  terms  set  forth in such  Subsequent
      Financing  Notice  within 60 Trading  Days  after the date of the  initial
      Subsequent Financing Notice.

      Notwithstanding  the  foregoing,  this  Section  4.13  shall  not apply in
respect of an Exempt Issuance.

                                    ARTICLE V
                                  MISCELLANEOUS

      5.1 Fees and Expenses.  Except as otherwise  set forth in this  Agreement,
each party shall pay the fees and expenses of its advisers, counsel, accountants
and  other  experts,  if any,  and all other  expenses  incurred  by such  party
incident to the negotiation, preparation, execution, delivery and performance of
this  Agreement.  The  Company  shall pay all stamp and other  taxes and  duties
levied in connection with the sale of the Securities.

      5.2  Entire  Agreement.  The  Transaction  Documents,  together  with  the
exhibits and schedules thereto,  contain the entire understanding of the parties
with respect to the subject matter hereof and supersede all prior agreements and
understandings, oral or written, with respect to such matters, which the parties
acknowledge have been merged into such documents, exhibits and schedules.

                                       20
<PAGE>

      5.3 Notices.  Any and all notices or other  communications  or  deliveries
required or permitted to be provided  hereunder shall be in writing and shall be
deemed given and effective on the earliest of (a) the date of  transmission,  if
such notice or  communication is delivered via facsimile at the facsimile number
specified  on the  signature  page prior to 5:30 p.m.  (New York City time) on a
Trading  Day and an  electronic  confirmation  of  delivery  is  received by the
sender, (b) the next Trading Day after the date of transmission,  if such notice
or communication is delivered via facsimile at the facsimile number specified in
this  Section on a day that is not a Trading  Day or later  than 5:30 p.m.  (New
York City time) on any Trading Day, (c) three Trading Days following the date of
mailing, if sent by U.S. nationally recognized overnight courier service, or (d)
upon  actual  receipt by the party to whom such  notice is required to be given.
The  addresses  for such notices and  communications  are those set forth on the
signature  pages  hereof,  or such other address as may be designated in writing
hereafter, in the same manner, by such Person.

      5.4 Amendments;  Waivers.  No provision of this Agreement may be waived or
amended except in a written instrument  signed, in the case of an amendment,  by
the Company and each Purchaser or, in the case of a waiver, by the party against
whom  enforcement  of any such waiver is sought.  No waiver of any default  with
respect to any provision,  condition or  requirement of this Agreement  shall be
deemed to be a  continuing  waiver in the  future or a waiver of any  subsequent
default or a waiver of any other provision, condition or requirement hereof, nor
shall any delay or omission of either party to exercise  any right  hereunder in
any manner impair the exercise of any such right.

      5.5  Construction.  The headings herein are for  convenience  only, do not
constitute a part of this  Agreement  and shall not be deemed to limit or affect
any of the provisions hereof. The language used in this Agreement will be deemed
to be the language chosen by the parties to express their mutual intent,  and no
rules of strict construction will be applied against any party.

      5.6 Successors and Assigns. This Agreement shall be binding upon and inure
to the benefit of the parties and their  successors and permitted  assigns.  The
Company may not assign this  Agreement  or any rights or  obligations  hereunder
without the prior written  consent of each  Purchaser.  Any Purchaser may assign
any or all of its  rights  under  this  Agreement  to any  Person  to whom  such
Purchaser  assigns or transfers any Securities,  provided such transferee agrees
in  writing to be bound,  with  respect to the  transferred  Securities,  by the
provisions hereof that apply to the "Purchasers".

      5.7 No  Third-Party  Beneficiaries.  This  Agreement  is intended  for the
benefit of the parties  hereto and their  respective  successors  and  permitted
assigns and is not for the benefit of, nor may any provision  hereof be enforced
by, any other Person, except as otherwise set forth in this Agreement.

      5.8 Governing Law. All questions  concerning the  construction,  validity,
enforcement and interpretation of the Transaction Documents shall be governed by
and construed and enforced in accordance  with the internal laws of the State of
New York,  without  regard to the  principles of conflicts of law thereof.  Each
party  agrees  that  all  legal  proceedings   concerning  the  interpretations,
enforcement and defense of the  transactions  contemplated by this Agreement and
any other Transaction  Documents  (whether brought against a party hereto or its
respective affiliates,  directors, officers, shareholders,  employees or agents)
shall be commenced  exclusively  in the state and federal  courts sitting in the
City of New  York.  Each  party  hereby  irrevocably  submits  to the  exclusive
jurisdiction  of the state and federal  courts  sitting in the City of New York,
borough  of  Manhattan  for the  adjudication  of any  dispute  hereunder  or in
connection  herewith or with any  transaction  contemplated  hereby or discussed
herein  (including  with respect to the  enforcement  of any of the  Transaction
Documents), and hereby irrevocably waives, and agrees not to assert in any suit,
action  or  proceeding,  any  claim  that it is not  personally  subject  to the
jurisdiction of any such court, that such suit, action or proceeding is improper
or inconvenient venue for such proceeding.  Each party hereby irrevocably waives
personal  service of process and  consents to process  being  served in any such
suit, action or proceeding by mailing a copy thereof via registered or certified
mail or  overnight  delivery  (with  evidence of  delivery) to such party at the
address in effect for  notices to it under this  Agreement  and agrees that such
service  shall  constitute  good and  sufficient  service of process  and notice
thereof.  Nothing contained herein shall be deemed to limit in any way any right
to serve  process in any manner  permitted by law. The parties  hereby waive all
rights  to a trial  by jury.  If  either  party  shall  commence  an  action  or
proceeding to enforce any  provisions  of the  Transaction  Documents,  then the
prevailing  party in such action or proceeding  shall be reimbursed by the other
party for its  attorneys'  fees and other costs and expenses  incurred  with the
investigation, preparation and prosecution of such action or proceeding.

                                       21
<PAGE>

      5.9 Survival.  The representations  and warranties  contained herein shall
survive  the  Closing  and  the  delivery,  exercise  and/or  conversion  of the
Securities, as applicable.

      5.10   Execution.   This   Agreement  may  be  executed  in  two  or  more
counterparts,  all of which when taken  together shall be considered one and the
same agreement and shall become effective when  counterparts have been signed by
each party and  delivered  to the other  party,  it being  understood  that both
parties need not sign the same  counterpart.  In the event that any signature is
delivered by facsimile  transmission,  such  signature  shall create a valid and
binding  obligation of the party executing (or on whose behalf such signature is
executed)  with the same force and effect as if such  facsimile  signature  page
were an original thereof.

      5.11  Severability.  If any  provision  of  this  Agreement  is held to be
invalid or unenforceable in any respect,  the validity and enforceability of the
remaining  terms  and  provisions  of  this  Agreement  shall  not in any way be
affected or impaired  thereby and the parties will attempt to agree upon a valid
and enforceable provision that is a reasonable substitute therefor,  and upon so
agreeing, shall incorporate such substitute provision in this Agreement.

      5.12  Rescission and  Withdrawal  Right.  Notwithstanding  anything to the
contrary  contained in (and  without  limiting  any similar  provisions  of) the
Transaction  Documents,  whenever  any  Purchaser  exercises a right,  election,
demand or option  under a  Transaction  Document and the Company does not timely
perform its related  obligations within the periods therein provided,  then such
Purchaser may rescind or withdraw, in its sole discretion from time to time upon
written notice to the Company, any relevant notice,  demand or election in whole
or in part  without  prejudice  to its  future  actions  and  rights;  provided,
however,  in the case of a rescission of a conversion of the Preferred  Stock or
exercise of the Warrant, the Purchaser shall be required to return any shares of
Common Stock subject to such conversion or exercise notice.

                                       22
<PAGE>

      5.13   Replacement  of  Securities.   If  any  certificate  or  instrument
evidencing any Securities is mutilated,  lost, stolen or destroyed,  the Company
shall  issue or cause to be issued in  exchange  and  substitution  for and upon
cancellation thereof, or in lieu of and substitution therefor, a new certificate
or instrument,  but only upon receipt of evidence reasonably satisfactory to the
Company  of such  loss,  theft  or  destruction  and  customary  and  reasonable
indemnity,  if requested.  The  applicants  for a new  certificate or instrument
under  such  circumstances  shall  also  pay any  reasonable  third-party  costs
associated with the issuance of such replacement Securities.

      5.14  Remedies.  In  addition to being  entitled  to  exercise  all rights
provided herein or granted by law, including  recovery of damages,  each of each
Purchaser  and the Company  will be entitled to specific  performance  under the
Transaction  Documents.  The  parties  agree that  monetary  damages  may not be
adequate  compensation  for  any  loss  incurred  by  reason  of any  breach  of
obligations  described in the  foregoing  sentence and hereby agrees to waive in
any action for specific  performance  of any such  obligation the defense that a
remedy at law would be adequate.

      5.15 Payment Set Aside.  To the extent that the Company makes a payment or
payments to any Purchaser  pursuant to any  Transaction  Document or a Purchaser
enforces or exercises its rights thereunder, and such payment or payments or the
proceeds of such  enforcement  or exercise or any part thereof are  subsequently
invalidated,  declared to be fraudulent or  preferential,  set aside,  recovered
from, disgorged by or are required to be refunded,  repaid or otherwise restored
to the  Company,  a  trustee,  receiver  or  any  other  person  under  any  law
(including, without limitation, any bankruptcy law, state or federal law, common
law or equitable  cause of action),  then to the extent of any such  restoration
the  obligation  or part thereof  originally  intended to be satisfied  shall be
revived and  continued  in full force and effect as if such payment had not been
made or such enforcement or setoff had not occurred.

      5.16  Independent  Nature  of  Purchasers'  Obligations  and  Rights.  The
obligations of each Purchaser under any Transaction Document are several and not
joint with the  obligations of any other  Purchaser,  and no Purchaser  shall be
responsible  in any way for the  performance  of the  obligations  of any  other
Purchaser under any Transaction  Document.  Nothing  contained  herein or in any
Transaction  Document,  and no action taken by any Purchaser  pursuant  thereto,
shall be deemed to constitute the Purchasers as a partnership, an association, a
joint  venture  or any other kind of entity,  or create a  presumption  that the
Purchasers  are in any way acting in concert or as a group with  respect to such
obligations or the transactions  contemplated by the Transaction Document.  Each
Purchaser  shall be  entitled to  independently  protect and enforce its rights,
including without limitation, the rights arising out of this Agreement or out of
the other  Transaction  Documents,  and it shall not be necessary  for any other
Purchaser  to be  joined  as an  additional  party  in any  proceeding  for such
purpose.  Each Purchaser has been  represented by its own separate legal counsel
in their review and  negotiation of the Transaction  Documents.  The Company has
elected to provide all Purchasers with the same terms and Transaction  Documents
for the  convenience of the Company and not because it was required or requested
to do so by the Purchasers.

                                       23
<PAGE>

      5.17  Liquidated  Damages.  The Company's  obligations  to pay any partial
liquidated  damages or other amounts owing under the Transaction  Documents is a
continuing  obligation of the Company and shall not  terminate  until all unpaid
partial liquidated damages and other amounts have been paid  notwithstanding the
fact that the instrument or security  pursuant to which such partial  liquidated
damages or other amounts are due and payable shall have been canceled.

      5.18  Construction.  The  parties  agree  that each of them  and/or  their
respective counsel has reviewed and had an opportunity to revise the Transaction
Documents and, therefore, the normal rule of construction to the effect that any
ambiguities are to be resolved  against the drafting party shall not be employed
in the interpretation of the Transaction Documents or any amendments hereto.

                            [SIGNATURE PAGE FOLLOWS]

                                       24
<PAGE>

      IN WITNESS  WHEREOF,  the  parties  hereto  have  caused  this  Securities
Purchase   Agreement  to  be  duly  executed  by  their  respective   authorized
signatories as of the date first indicated above.

ACCUPOLL HOLDING CORP.                             Address for Notice:
                                                   -------------------

By: /s/ William E. Nixon
   ---------------------------------------
   Name:  William E. Nixon                        15101 Red Hill Ave., Suite 220
   Title: Chief Executive Officer                       Tustin, CA 92780
                                                        (949) 200-4000

With a copy to (which shall not constitute notice):

Sichenzia Ross Friedman Ference LLP
1065 Avenue of the Americas
T 212-930-9700
F 212-930-9725

                   [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK
                      SIGNATURE PAGE FOR PURCHASER FOLLOWS]

                                       25
<PAGE>

        [PURCHASER SIGNATURE PAGES TO ACUP SECURITIES PURCHASE AGREEMENT]

      IN WITNESS WHEREOF,  the undersigned have caused this Securities  Purchase
Agreement to be duly executed by their respective  authorized  signatories as of
the date first indicated above.
<TABLE>
<CAPTION>

Name of Purchaser: LEMANIK SICAV ACTIVE MULTYSTRATEGY
<S>                                              <C>
Signature of Authorized Signatory of Purchaser:  /s/ Michele Zorzi /s/ Carlo Sagramoso
Name of Authorized Signatory:  MICHELE ZORZI                  CARLO SAGRAMOSO
                              -----------------------------------------------
Title of Authorized Signatory: member of the board          member of the board
                                ------------------------------------------------
Email Address of Authorized Signatory:
                                      ----------------------------------------
</TABLE>

Address for Notice of Investing Entity:

Address for Delivery of Securities for Investing Entity (if not same as above):

Subscription Amount: $80,000
Shares of Preferred Stock: 800
Warrant Shares: 800,000 warrants of common shs (strike $0.10) + 800,000 warrants
of common shs (strike $0.125)
EIN Number:  [PROVIDE THIS UNDER SEPARATE COVER]

                           [SIGNATURE PAGES CONTINUE]

                                       26
<PAGE>

                              DISCLOSURE SCHEDULES

ACUP USE OF PROCEEDS

ASSUMING A $1 MILLION  BRIDGE

      o     150K Musco settlement
      o     550K Operations for 2 months
      o     100K Certification for Surecount and California
      o     100K Legal and accounting
      o     100K Offering costsEXHIBIT 10.6

                            SHARE EXCHANGE AGREEMENT

      SHARE EXCHANGE AGREEMENT (this  "Agreement"),  dated July __, 2005, by and
between Akid Corporation  ("Akid"),  a Colorado corporation having an address at
34 West 33rd  Street,  New York,  NY 10001,  and  Leonard  Cohen  ("Cohen"),  an
individual having an address at 750 Broad Street, Shrewsbury, NJ 07702.

                              W I T N E S S E T H :

      WHEREAS,   Mazal  Plant   Pharmaceuticals,   Inc.  ("Mazal"),  a  Delaware
corporation, is a subsidiary of Akid;

      WHEREAS,  pursuant to a Subscription Agreement dated April 11, 2005, Cohen
purchased One Hundred Twenty  Thousand  (120,000)  shares of the common stock of
Mazal (the "Mazal Shares");

      WHEREAS,  the parties  hereto desire that Cohen  exchange the Mazal Shares
for One Hundred  Twenty  Thousand  (120,000)  shares of the common stock of Akid
(the "Exchange Shares") in accordance with the terms hereof;

      NOW,   THEREFORE,   in  consideration  of  the  covenants,   promises  and
representations set forth herein, and for other good and valuable consideration,
the receipt and sufficiency of which is hereby acknowledged, and intending to be
legally bound hereby, the parties agree as follows:

1. Share  Exchange.  Subject to the terms and conditions  stated herein,  at the
Closing, (a) Cohen shall assign, transfer, convey, and deliver to Akid, and Akid
shall accept and acquire, the Mazal Shares and any and all rights in such shares
to which he is entitled,  and by doing so will be deemed to have assigned all of
his right,  title and interest in and to all such Mazal Shares to Akid,  and (b)
Akid shall issue to Cohen,  and Cohen shall  accept and acquire  from Akid,  the
Exchange  Shares   (collectively,   the  "Exchange").   If  one  or  more  stock
certificates  representing the Mazal Shares has been issued,  such conveyance of
the Mazal Shares shall be evidenced by such stock certificate(s),  duly endorsed
in blank or  accompanied  by stock  powers  duly  executed  in  blank,  or other
instruments of transfer in form and substance reasonably satisfactory to Akid.

2. The Closing.  The closing (the  "Closing") of the  transactions  contemplated
hereunder shall take place  simultaneously  with the execution of this Agreement
at such place as the parties may agree.

3. Representations and Warranties; Indemnification.

      3.1  Representations  and Warranties of Cohen. As an inducement to Akid to
enter  into this  Agreement  and to  consummate  the  transactions  contemplated
herein, Cohen represents and warrants to Akid as follows:
<PAGE>

      (a)  Authority.  Cohen has the right,  power,  authority  and  capacity to
execute and deliver this Agreement, to consummate the transactions  contemplated
hereby and to perform  his  obligations  under this  Agreement.  This  Agreement
constitutes  the legal,  valid and  binding  obligations  of Cohen,  enforceable
against Cohen in accordance with the terms hereof.

      (b) Ownership.  Cohen is the sole record and beneficial owner of the Mazal
Shares, has good and marketable title to the Mazal Shares, free and clear of all
Encumbrances  (hereafter  defined),  and has full legal right and power to sell,
transfer and deliver the Mazal Shares to Akid in accordance with this Agreement.
"Encumbrances"  means  any  liens,  pledges,  hypothecations,  charges,  adverse
claims,  options,   preferential  arrangements  or  restrictions  of  any  kind,
including,  without  limitation,  any restriction of the use, voting,  transfer,
receipt of income or other exercise of any  attributes of ownership,  other than
as provided under applicable securities laws. Upon the execution and delivery of
this Agreement, Akid will receive good and marketable title to the Mazal Shares,
free and  clear of all  Encumbrances.  There  are no  stockholders'  agreements,
voting trust, proxies,  options, rights of first refusal or any other agreements
or understandings with respect to the Mazal Shares.

      (c) No Conflict.  None of the execution,  delivery, or performance of this
Agreement,  and  the  consummation  of  the  transactions  contemplated  hereby,
conflicts or will conflict with, or (with or without notice or lapse of time, or
both)  result in a  termination,  breach  or  violation  of (i) any  instrument,
contract or agreement  to which Cohen is a party or by which he is bound,  or to
which the Mazal Shares are subject; or (ii) any federal, state, local or foreign
law, ordinance,  judgment, decree, order, statute, or regulation, or that of any
other governmental body or authority, applicable to Cohen or the Mazal Shares.

      (d) No Consent.  No consent,  approval,  authorization or order of, or any
filing or  declaration  with any  governmental  authority or any other person is
required for the  consummation  by the Cohen of any of the  transactions  on its
part contemplated under this Agreement.

      (e) Own  Account.  Cohen is  acquiring  the  Exchange  Shares  for his own
account as principal,  not as a nominee or agent, for investment  purposes only,
and not  with a view  to,  or for,  resale,  distribution  or  fractionalization
thereof  in  whole  or in part and no other  person  has a  direct  or  indirect
beneficial  interest in such Exchange  Shares or any portion  thereof.  Further,
Cohen does not have any contract, undertaking, agreement or arrangement with any
person to sell, transfer or grant  participations to such person or to any third
person, with respect to the Exchange Shares.

      (f) No  Advertisement.  Cohen is not  acquiring  the Exchange  Shares as a
result  of  or  subsequent  to  any  advertisement,  article,  notice  or  other
communication published in any newspaper, magazine or similar media or broadcast
over  television  or radio,  or  presented  at any  seminar or  meeting,  or any
solicitation  of a  subscription  by  person  previously  not  known to Cohen in
connection with investment securities generally.
<PAGE>

      (g) No Obligation to Register. Cohen understands that, except as set forth
herein,  Akid is under no obligation  to register the Exchange  Shares under the
Securities Act of 1933, as amended (the "Act"),  or to assist Cohen in complying
with the Act or the securities  laws of any state of the United States or of any
foreign jurisdiction.

      (h) Experience. Cohen is (1) experienced in making investments of the kind
described in this  Agreement and the related  documents,  (2) able, by reason of
the  business  and  financial  experience  of its  officers  (if an entity)  and
professional  advisors (who are not affiliated with or compensated in any way by
Akid or any of its affiliates or selling  agents),  to protect its own interests
in connection with the transactions described in this Agreement, and the related
documents,  and (3) able to afford  the  entire  loss of its  investment  in the
Exchange Shares.

      (i) Exemption from Registration. Cohen acknowledges his understanding that
the offering and sale Exchange Shares is intended to be exempt from registration
under the Act. In furtherance thereof, in addition to the other  representations
and  warranties of Cohen made herein,  Cohen further  represents and warrants to
and agrees with the Company and its affiliates as follows:

            (1)  Cohen  realizes  that the basis  for the  exemption  may not be
present  if,  notwithstanding  such  representations,  Cohen has in mind  merely
acquiring the Exchange Shares for a fixed or determinable  period in the future,
or for a market  rise,  or for sale if the market does not rise.  Cohen does not
have any such intention;

            (2) Cohen has the financial ability to bear the economic risk of his
investment,  has adequate means for providing for his current needs and personal
contingencies  and has no need for liquidity  with respect to his  investment in
Akid; and

            (3)  Cohen  has such  knowledge  and  experience  in  financial  and
business  matters  as to be capable  of  evaluating  the merits and risks of the
prospective investment in the Exchange Shares; and

            (4) Cohen has been provided an opportunity  for a reasonable  period
of time prior to the date hereof to obtain additional information concerning the
offering of the Exchange  Shares,  Akid and all other  information to the extent
Akid possesses such information or can acquire it without unreasonable effort or
expense.

            (5) Cohen has  carefully  reviewed all of Akid's  filings  under the
Securities Exchange Act of 1934, as amended (the "Exchange Act").
<PAGE>

      (j) Compliance  with Local Laws. Any resale of the Exchange  Shares during
the `distribution  compliance  period' as defined in Rule 902(f) to Regulation S
promulgated under the Act ("Regulation S") shall only be made in compliance with
exemptions from registration afforded by Regulation S. Further, any such sale of
the Exchange  Shares in any  jurisdiction  outside of the United  States will be
made in compliance with the securities laws of such jurisdiction. Cohen will not
offer to sell or sell the  Exchange  Shares  in any  jurisdiction  unless  Cohen
obtains all required consents, if any.

      (k) Regulation S Exemption. Cohen understands that the Exchange Shares are
being offered and sold to him in reliance on an exemption from the  registration
requirements of United States federal and state securities laws under Regulation
S promulgated under the Act and that Akid is relying upon the truth and accuracy
of   the   representations,    warranties,   agreements,   acknowledgments   and
understandings of Cohen set forth herein in order to determine the applicability
of such exemptions and the suitability of Cohen to acquire the Exchange  Shares.
In this regard, Cohen represents, warrants and agrees that:

            (1)  Cohen  is  not a  U.S.  Person  (as  defined  below)  and is an
affiliate (as defined in Rule 501(b) under the Act) of Akid and is not acquiring
the Exchange Shares for the account or benefit of a U.S.  Person.  A U.S. Person
means any one of the following:

                  (A) any  natural  person  resident  in the  United  States  of
America;

                  (B) any  partnership or corporation  organized or incorporated
under the laws of the United States of America;

                  (C) any estate of which any  executor  or  administrator  is a
U.S. person;

                  (D) any trust of which any trustee is a U.S. person;

                  (E) any  agency or branch of a foreign  entity  located in the
United States of America;

                  (F) any  non-discretionary  account or similar  account (other
than an estate or trust) held by a dealer or other  fiduciary for the benefit or
account of a U.S. person;

                  (G) any  discretionary  account or similar account (other than
an estate or trust) held by a dealer or other fiduciary organized,  incorporated
or (if an individual) resident in the United States of America; and

                  (H) any partnership or corporation if:

                        (i)  organized  or  incorporated  under  the laws of any
foreign jurisdiction; and

                        (ii) formed by a U.S. person principally for the purpose
of investing in securities not registered  under the Act, unless it is organized
or incorporated,  and owned, by accredited  investors (as defined in Rule 501(a)
under the Act) who are not natural persons, estates or trusts.
<PAGE>

            (2) At the  time  of the  origination  of  contact  concerning  this
Agreement and the date of the execution  and delivery of this  Agreement,  Cohen
was outside of the United States.

            (3) Cohen  will not,  during the  period  commencing  on the date of
issuance  of the  Exchange  Shares and ending on the first  anniversary  of such
date,  or such  shorter  period as may be  permitted  by  Regulation  S or other
applicable  securities law (the "Restricted  Period"),  offer,  sell,  pledge or
otherwise transfer the Exchange Shares in the United States, or to a U.S. Person
for the account or for the benefit of a U.S.  Person,  or  otherwise in a manner
that is not in compliance with Regulation S.

            (4) Cohen will,  after expiration of the Restricted  Period,  offer,
sell,  pledge or  otherwise  transfer  the  Exchange  Shares  only  pursuant  to
registration  under  the  Act  or  an  available  exemption  therefrom  and,  in
accordance with all applicable state and foreign securities laws.

            (5) Cohen was not in the United States, engaged in, and prior to the
expiration of the Restricted  Period will not engage in, any short selling of or
any hedging  transaction with respect to the Exchange Shares,  including without
limitation, any put, call or other option transaction,  option writing or equity
swap.

            (6)  Neither  Cohen  nor or any  person  acting  on his  behalf  has
engaged,  nor will engage, in any directed selling efforts to a U.S. Person with
respect to the  Exchange  Shares  and Cohen and any person  acting on his behalf
have complied and will comply with the "offering  restrictions"  requirements of
Regulation S under the Act.

            (7) The  transactions  contemplated  by this Agreement have not been
pre-arranged  with a buyer located in the United  States or with a U.S.  Person,
and are not part of a plan or scheme to evade the  registration  requirements of
the Act.

            (8) Neither Cohen nor any person acting on his behalf has undertaken
or carried out any  activity  for the purpose  of, or that could  reasonably  be
expected to have the effect of,  conditioning  the market in the United  States,
its territories or possessions, for any of the Exchange Shares. Cohen agrees not
to cause  any  advertisement  of the  Exchange  Shares  to be  published  in any
newspaper  or  periodical  or  posted in any  public  place and not to issue any
circular  relating  to the  Exchange  Shares,  except such  advertisements  that
include the statements required by Regulation S under the Act, and only offshore
and not in the U.S. or its  territories,  and only in compliance  with any local
applicable securities laws.

            (9) Each  certificate  representing  the  Exchange  Shares  shall be
endorsed with the following legends, in addition to any other legend required to
be placed thereon by applicable federal or state securities laws:
<PAGE>

                  (A) "THE SECURITIES ARE BEING OFFERED TO INVESTORS WHO ARE NOT
U.S.  PERSONS (AS DEFINED IN REGULATION S UNDER THE  SECURITIES  ACT OF 1933, AS
AMENDED ("THE SECURITIES ACT")) AND WITHOUT  REGISTRATION WITH THE UNITED STATES
SECURITIES  AND EXCHANGE  COMMISSION  UNDER THE  SECURITIES ACT IN RELIANCE UPON
REGULATION S PROMULGATED UNDER THE SECURITIES ACT."

                  (B)  "TRANSFER OF THESE  SECURITIES IS  PROHIBITED,  EXCEPT IN
ACCORDANCE WITH THE PROVISIONS OF REGULATION S, PURSUANT TO  REGISTRATION  UNDER
THE  SECURITIES  ACT, OR  PURSUANT TO  AVAILABLE  EXEMPTION  FROM  REGISTRATION.
HEDGING  TRANSACTIONS  MAY  NOT BE  CONDUCTED  UNLESS  IN  COMPLIANCE  WITH  THE
SECURITIES ACT."

            (10) Cohen  consents  to Akid  making a notation  on its  records or
giving  instructions  to any transfer  agent of Akid in order to  implement  the
restrictions on transfer of the Exchange Shares.

      (l) Accredited Investor. Cohen is an "accredited investor" as that term is
defined in Rule 501 of the General Rules and Regulations under the Act by reason
of Rule 501(a)(3).

      (m) Risk. Cohen understands that an investment in the Exchange Shares is a
speculative  investment  which  involves a high degree of risk and the potential
loss of his entire investment.

      (n) Net Worth.  Cohen's  overall  commitment to investments  which are not
readily  marketable  is  not  disproportionate  to  Cohen's  net  worth,  and an
investment  in the  Exchange  Shares will not cause such overall  commitment  to
become excessive.

      (o) SEC Documents.  Cohen has received all documents,  records,  books and
other  information  pertaining  to  Cohen's  investment  in Akid  that  has been
requested  by Cohen.  Cohen has  reviewed or received  copies of all reports and
other documents  filed by Akid with the Securities and Exchange  Commission (the
"SEC Documents").

      (p) Reliance.  Other than as set forth  herein,  Cohen is not relying upon
any  other  information,  representation  or  warranty  by Akid or any  officer,
director,  stockholder, agent or representative of Akid in determining to invest
in the Exchange Shares. Cohen has consulted, to the extent deemed appropriate by
Cohen,  with Cohen's own advisers as to the  financial,  tax,  legal and related
matters  concerning  an  investment  in the  Exchange  Shares  and on that basis
believes  that his or its  investment  in the  Exchange  Shares is suitable  and
appropriate for Cohen.
<PAGE>

      (q) No Governmental Review. Cohen is aware that no federal or state agency
has (1) made any finding or determination as to the fairness of this investment,
(2) made any  recommendation  or endorsement of the Exchange  Shares or Akid, or
(3)  guaranteed  or  insured  any  investment  in  the  Exchange  Shares  or any
investment made by Akid.

      (r) Price. Cohen understands that the price of the Exchange Shares offered
hereby bear no relation to the assets,  book value or net worth of Akid and were
determined  arbitrarily  by Akid.  Cohen  further  understands  that  there is a
substantial risk of further dilution on his or its investment in Akid.

      (s) Full  Disclosure.  No  representation  or warranty of Cohen to Akid in
this  Agreement  omits to state a material fact necessary to make the statements
herein,  in light of the  circumstances in which they were made, not misleading.
There is no fact known to Cohen that has specific  application to the Shares and
that  materially  adversely  affects or, as far as can be  reasonably  foreseen,
materially threatens the Shares that has not been set forth in this Agreement.

      3.2  Representations  and Warranties of Akid. As an inducement to Cohen to
enter  into this  Agreement  and to  consummate  the  transactions  contemplated
herein, Akid represents and warrants to Cohen as follows:

      (a) Organization of Akid. Akid is a corporation duly organized and validly
existing and in good standing  under the laws of the State of Colorado,  and has
all requisite  power and authority to own,  lease and operate its properties and
to carry on its  business as now being  conducted.  Akid is duly  qualified as a
foreign corporation to do business and is in good standing in every jurisdiction
in which the nature of the business conducted or property owned by it makes such
qualification  necessary,  other than  those in which the  failure so to qualify
would  not  have  a  material  adverse  effect  on  the  business,   operations,
properties, prospects or condition (financial or otherwise) of Akid.

      (b) Authority. (1) Akid has the requisite corporate power and authority to
enter into and perform its  obligations  under this  Agreement  and to issue the
Exchange  Shares;  (2) the execution and delivery of this  Agreement by Akid and
the consummation by it of the transactions  contemplated hereby and thereby have
been duly authorized by all necessary corporate action and no further consent or
authorization of Akid or its Board of Directors or stockholders is required; and
(3) this Agreement has been duly executed and delivered by Akid and  constitutes
a valid and binding  obligation of Akid  enforceable  against Akid in accordance
with its terms,  except as such  enforceability  may be  limited  by  applicable
bankruptcy,  insolvency, or similar laws relating to, or affecting generally the
enforcement of, creditors' rights and remedies or by other equitable  principles
of general application.

      (c) SEC  Documents.  To the  best of  Company's  knowledge,  Akid  has not
provided to Cohen any  information  that,  according to applicable  law, rule or
regulation,  should  have been  disclosed  publicly  prior to the date hereof by
Akid, but which has not been so disclosed. As of their respective dates, the SEC
Documents  complied in all material respects with the requirements of the Act or
the Exchange Act, as the case may be, and other  federal,  state and local laws,
rules and  regulations  applicable  to such SEC  Documents,  and none of the SEC
Documents  contained any untrue statement of a material fact or omitted to state
a material fact required to be stated  therein or necessary in order to make the
statements  therein,  in light of the circumstances  under which they were made,
not misleading.  The financial  statements of Akid included in the SEC Documents
<PAGE>

comply  as to form  and  substance  in all  material  respects  with  applicable
accounting   requirements  and  the  published  rules  and  regulations  of  the
Securities and Exchange  Commission  (the "SEC") or other  applicable  rules and
regulations with respect thereto.  Such financial  statements have been prepared
in  accordance  with  generally  accepted  accounting  principles  applied  on a
consistent  basis  during the periods  involved  (except (1) as may be otherwise
indicated in such  financial  statements or the notes thereto or (2) in the case
of unaudited interim statements, to the extent they may not include footnotes or
may be  condensed  or summary  statements)  and fairly  present in all  material
respects the financial  position of Akid as of the dates thereof and the results
of operations and cash flows for the periods then ended (subject, in the case of
unaudited statements, to normal year-end audit adjustments).

      (d) Exemption from Registration; Valid Issuances. The sale and issuance of
the  Exchange  Shares,  in  accordance  with the  terms  and on the bases of the
representations  and  warranties  of Cohen  set forth  herein,  may and shall be
properly  issued by Akid to Cohen  pursuant to any  applicable  federal or state
law. When issued and paid for as herein  provided,  the Exchange Shares shall be
duly and validly issued, fully paid, and nonassessable. Neither the sales of the
Exchange  Shares pursuant to, nor Akid's  performance of its obligations  under,
this  Agreement  shall (1) result in the  creation or  imposition  of any liens,
charges,  claims or other  encumbrances  upon the Exchange  Shares or any of the
assets of Akid,  or (2) entitle the other holders of the Common Stock of Akid to
preemptive  or other rights to subscribe to or acquire the Common Stock or other
securities  of Akid.  The Exchange  Shares  shall not subject  Cohen to personal
liability by reason of the ownership thereof.

      (e) No General  Solicitation or Advertising in Regard to this Transaction.
Neither  Akid nor any of its  affiliates  nor any person  acting on its or their
behalf (1) has conducted or will conduct any general  solicitation (as that term
is used in Rule 502(c) of Regulation D) or general  advertising  with respect to
any of the Exchange  Shares,  or (2) made any offers or sales of any security or
solicited  any offers to buy any  security  under any  circumstances  that would
require registration of the Common Stock under the Act.

      (f)  No  Conflicts.  The  execution,  delivery  and  performance  of  this
Agreement by Akid and the consummation by Akid of the transactions  contemplated
hereby, including without limitation the issuance of the Exchange Shares, do not
and will not (1) result in a violation of the  Certificate or By-Laws of Akid or
(2)  conflict  with,  or  constitute  a material  default (or an event that with
notice or lapse of time or both would become a material  default) under, or give
to others any rights of termination, amendment, acceleration or cancellation of,
any  material  agreement,  indenture,  instrument  or any  "lock-up"  or similar
provision of any underwriting or similar  agreement to which Akid is a party, or
(3) result in a violation of any  federal,  state,  local or foreign law,  rule,
regulation,  order,  judgment or decree (including  federal and state securities
laws and  regulations)applicable  to Akid or by which any  property  or asset of
Akid is bound or affected  (except for such conflicts,  defaults,  terminations,
amendments,   accelerations,   cancellations   and   violations  as  would  not,
individually  or in  the  aggregate,  have  a  material  adverse  effect  on the
business,   operations,   properties,   prospects  or  condition  (financial  or
otherwise) of Akid) nor is Akid  otherwise in violation of,  conflict with or in
default under any of the foregoing.  The business of Akid is not being conducted
in violation of any law,  ordinance or  regulation of any  governmental  entity,
except for possible violations that either singly or in the aggregate do not and
will not have a material adverse effect on the business, operations, properties,
prospects or condition  (financial or  otherwise) of Akid.  Akid is not required
under  federal,  state or local law,  rule or  regulation to obtain any consent,
authorization or order of, or make any filing or registration with, any court or
governmental  agency in order for it to  execute,  deliver or perform any of its
obligations  under  this  Agreement  or  issue  and  sell  the  Common  Stock in
accordance  with the terms hereof (other than any SEC, NASD or state  securities
filings that may be required to be made by Akid  subsequent to the Closing,  any
registration  statement that may be filed pursuant  hereto,  and any shareholder
approval required by the rules applicable to companies whose common stock trades
on the Over The Counter  Bulletin  Board);  provided  that,  for purposes of the
representation  made in this  sentence,  Akid is assuming  and relying  upon the
accuracy of the relevant representations and agreements of Cohen herein.
<PAGE>

      (g) No  Undisclosed  Liabilities.  Akid has no  liabilities or obligations
that are material,  individually or in the aggregate, and that are not disclosed
in the SEC Documents or otherwise publicly announced,  other than those incurred
in the ordinary  course of Akid's  businesses and which,  individually or in the
aggregate, do not or would not have a material adverse effect on Akid.

      (h) No Undisclosed  Events or Circumstances.  No event or circumstance has
occurred  or  exists  with  respect  to  Akid  or  its  businesses,  properties,
prospects,  operations or financial condition,  that, under applicable law, rule
or regulation,  requires  public  disclosure or  announcement  prior to the date
hereof by Akid but which has not been so publicly  announced or disclosed in the
SEC Documents.

      (i)  Litigation and Other  Proceedings.  Except as may be set forth in the
SEC  Documents,  there are no  lawsuits  or  proceedings  pending or to the best
knowledge of Akid threatened, against Akid, nor has Akid received any written or
oral notice of any such action, suit,  proceeding or investigation,  which would
have  a  material  adverse  effect  on  the  business,  operations,  properties,
prospects or condition  (financial or otherwise) of Akid. Except as set forth in
the SEC Documents,  no judgment,  order, writ, injunction or decree or award has
been  issued  by  or,  so far as is  known  by  Akid,  requested  of any  court,
arbitrator or governmental  agency which would have a material adverse effect on
the  business,  operations,  properties,  prospects or condition  (financial  or
otherwise) of Akid.

      3.3  Indemnification.  Cohen shall  indemnify  and hold  harmless Akid and
Akid's agents, beneficiaries,  affiliates,  representatives and their respective
successors   and  assigns  from  and  against  any  and  all  damages,   losses,
liabilities,  taxes and  costs  and  expenses  (including,  without  limitation,
attorneys'  fees  and  costs)  resulting  directly  or  indirectly  from (a) any
inaccuracy,  misrepresentation,  breach of warranty or non-fulfillment of any of
the representations  and warranties of Cohen in this Agreement,  or any actions,
omissions or statements of fact  inconsistent  with in any material  respect any
such  representation or warranty,  (b) any failure by Cohen to perform or comply
with any agreement, covenant or obligation in this Agreement.
<PAGE>

4. Piggy-Back Registration Rights.

      4.1  Right  to  include  Registrable  Securities.  For  purposes  of  this
Agreement,  "Registrable Securities" means Sixty Thousand (60,000) shares of the
Exchange  Shares.  If at any time, Akid shall determine to prepare and file with
the Securities and Exchange Commission,  a registration statement relating to an
offering for its own account or the account of others,  under the Act, of any of
its  equity  securities,  other  than on Form S-4 or Form S-8 (each  promulgated
under the Act) or their then  equivalents  relating to equity  securities  to be
issued in connection with an underwritten  offering for its own account or other
holders  of  Akid's  shares of Common  Stock or  securities  to be issued in any
acquisition  of  any  entity  or  business  or  equity  securities  issuable  in
connection with stock options or other employee benefit plans (the "Registration
Statement"),  then Akid shall send to Cohen written notice of such determination
and if,  within  fifteen  (15) days after  receipt of such notice Cohen shall so
request in writing, Akid shall include in such registration statement all or any
part of the  Registrable  Securities,  as Cohen requests to be registered.  Akid
shall keep such Registration Statement current and maintain compliance with each
Federal and state law or regulation  for the period  necessary for such Cohen to
effectuate  the proposed  sale or to otherwise be eligible to  effectuate a sale
pursuant to Rule 144 of the Act.

      4.2  Registration  of  Underwritten  Public  Offerings.  Anything  to  the
contrary herein notwithstanding,  if the registration involves an offering by or
through underwriters, then (a) Cohen must sell its Registrable Securities to the
underwriters selected by Akid on the same terms and conditions as apply to other
selling  securityholders;  and (b) Cohen may elect in  writing,  not later  than
three business days prior to the  effectiveness  of the  Registration  Statement
filed  in  connection  with  such  registration,  not to  have  its  Registrable
Securities so included in connection with such registration.

      4.3 Priority in Registration. Notwithstanding anything contained herein to
the  contrary,   if  this  registration  involves  an  offering  by  or  through
underwriters,  Akid  shall not be  required  to include  Registrable  Securities
therein,  if and to the extent the underwriter  managing the offering reasonably
believes in good faith and advises Cohen that such  inclusion  would  materially
adversely affect such offering;  provided that any such reduction or elimination
shall  be pro  rata  to all  other  securityholders  of the  securities  of Akid
entitled to registration rights in proportion to the respective number of shares
they have requested to be registered.

      4.4 Registration Procedures.

            (a) If and  whenever  Akid  takes  action  to  register  Registrable
Securities on behalf of Cohen, it shall, as expeditiously as practicable:
<PAGE>

                  (1) Furnish to Cohen and each  managing  underwriter,  without
charge,  at  least  one  signed  copy  of the  Registration  Statement  and  any
post-effective amendment thereto,  including financial statements and schedules,
all  documents  incorporated  therein by reference  and all exhibits  (including
those incorporated by reference)

                  (2)  Deliver to Cohen and the  underwriters,  if any,  without
charge,  as many  copies  of the  prospectus  or  prospectuses  (including  each
preliminary prospectus), any amendment or supplement thereto as such persons may
reasonably request; Akid consents to the use of such prospectus or any amendment
or supplement thereto by Cohen and the underwriters,  if any, in connection with
the offering and sale of the Registrable  Securities  covered by such prospectus
or any amendment or supplement thereto;

                  (3) Prior to any public  offering of  Registrable  Securities,
cooperate with Cohen, the underwriters,  if any, and their respective counsel in
connection with the registration or qualification of such Registrable Securities
for offer and sale under the  securities or Blue Sky laws of such  jurisdictions
within the  United  States as Cohen or an  underwriter  reasonably  requests  in
writing,  keep each such  registration  or  qualification  effective  during the
period such  Registration  Statement is required to be kept effective and do any
and all other acts or things necessary or advisable to enable the disposition in
such  jurisdictions  of the  Registrable  Securities  covered by the  applicable
Registration Statement; provided that Akid will not be required to qualify to do
business in any  jurisdiction  where it is not then so  qualified or to take any
action  which  would  subject  Akid  to  general   service  of  process  in  any
jurisdiction where it is not at the time so subject;

                  (4)  Cooperate  with Cohen and the managing  underwriters,  if
any,  to  facilitate  the  timely   preparation  and  delivery  of  certificates
representing  Registrable  Securities to be sold and not bearing any restrictive
legends; and enable such Registrable  Securities to be in such denominations and
registered in such names as the managing  underwriters  may request at least two
(2)  business  days  prior  to  any  sale  of  Registrable   Securities  to  the
underwriters;

                  (5) Use its best efforts to cause the  Registrable  Securities
covered  by the  applicable  Registration  Statement  to be  registered  with or
approved by such other  governmental  agencies or authorities  within the United
States as may be  necessary  to enable  the  seller or  sellers  thereof  or the
underwriters,  if  any,  to  consummate  the  disposition  of  such  Registrable
Securities;

                  (6)  With  respect  to each  issue  or  class  of  Registrable
Securities,  use its best efforts to cause all Registrable Securities covered by
the Registration Statements to be listed on each securities exchange, if any, on
which  similar  securities  issued by Akid are then listed if  requested  by the
majority of such issue or class of Registrable Securities;
<PAGE>

                  (7) Enter  into such  agreements  (including  an  underwriting
agreement)  and take all such other  action  reasonably  required in  connection
therewith in order to expedite or facilitate the disposition of such Registrable
Securities and in such connection,  if the registration is in connection with an
underwritten  offering  (i) make  such  representations  and  warranties  to the
underwriters,  in such  form,  substance  and scope as are  customarily  made by
issuers to underwriters  in  underwritten  offerings and confirm the same if and
when  requested;  (ii) obtain  opinions  of counsel to Akid and updates  thereof
(which  counsel shall be reasonably  acceptable  to the  underwriters  and which
opinions shall be in form,  scope and substance  reasonably  satisfactory to the
underwriters)  addressed to the  underwriters  covering the matters  customarily
covered in opinions  requested in underwritten  offerings and such other matters
as may be reasonably requested by such underwriters; (iii) obtain "cold comfort"
letters  and  updates   thereof  from  Akid's   accountants   addressed  to  the
underwriters,  such letters to be in customary form and covering  matters of the
type customarily covered in "cold comfort" letters by underwriters in connection
with  underwritten  offerings;  (iv)  set  forth  in  full  in any  underwriting
agreement entered into, the indemnification provisions and procedures of Section
5.3 hereof  with  respect  to all  parties to be  indemnified  pursuant  to said
Section;  and (v) deliver such documents and  certificates  as may be reasonably
requested by the  underwriters to evidence  compliance with clause (i) above and
with any customary conditions  contained in the underwriting  agreement or other
agreement  entered into by Akid;  the above shall be done at each closing  under
such  underwriting  or  similar  agreement  or as  and to  the  extent  required
hereunder;

                  (8)   Make   available   for   inspection   by  one  or   more
representatives  of Cohen,  any  underwriter  participating  in any  disposition
pursuant to such registration,  and any attorney or accountant retained by Cohen
or underwriter,  all financial and other records,  pertinent corporate documents
and  properties of Akid, and cause Akid's  officers,  directors and employees to
supply all  information  reasonably  requested by any such  representatives,  in
connection with such; and

                  (9)  Otherwise  use  its  best  efforts  to  comply  with  all
applicable federal and state  regulations;  and take such other action as may be
reasonably  necessary to or advisable  to enable Cohen and each  underwriter  to
consummate the sale or disposition in such jurisdiction or jurisdiction in which
Cohen or the underwriter shall have requested that the Registrable Securities be
sold.

            (b)  Except as  otherwise  provided  herein,  Akid  shall  have sole
control in connection with the  preparation,  filing,  withdrawal,  amendment or
supplementing of each Registration Statement, the selection of underwriters, and
the  distribution of any  preliminary  prospectus  included in the  Registration
Statement,  and may include  within the coverage  thereof  additional  shares of
Common Stock or other  securities  for its own account or for the account of one
or more of its other securityholders.

            (c) Akid may require each Cohen to furnish to Akid such  information
regarding the distribution of such securities and such other  information as may
otherwise be required by the Act to be included in such Registration Statement.
<PAGE>

5. Miscellaneous.

      (a)  Notices.  All notices or other  communications  required or permitted
hereunder  shall be in writing.  Any  notice,  request,  demand,  claim or other
communication  hereunder shall be deemed duly given (i) if by personal delivery,
when so  delivered,  (ii) if mailed,  three (3) business  days after having been
sent by registered or certified mail, return receipt requested,  postage prepaid
and  addressed  to the intended  recipient as set forth above,  or (iii) if sent
through an overnight  delivery  service in  circumstances  to which such service
guarantees next day delivery,  the day following being so sent to the address of
the  intended  recipient  as first set forth  above.  Any party may  change  the
address to which notices and other communications  hereunder are to be delivered
by giving the other parties notice in the manner herein set forth.

      (b)  Choice  of Law.  This  Agreement  shall be  governed,  construed  and
enforced  in  accordance  with the laws of the State of New York and the federal
laws of United States applicable therein, without giving effect to principles of
conflicts of law.

      (c)  Jurisdiction.  The  parties  hereby  irrevocably  consent  to  the in
personam jurisdiction of the state or federal courts located in the State of New
York, in connection with any action or proceeding  arising out of or relating to
this Agreement or the transactions and the relationships established thereunder.
The parties  hereby agree that such courts shall be the venue and  exclusive and
proper forum in which to adjudicate  such matters and that they will not contest
or challenge the jurisdiction or venue of these courts.

      (d) Entire  Agreement.  This Agreement sets forth the entire agreement and
understanding of the parties in respect of the transactions  contemplated hereby
and  supersedes  all  prior and  contemporaneous  agreements,  arrangements  and
understandings  of  the  parties  relating  to the  subject  matter  hereof.  No
representation, promise, inducement, waiver of rights, agreement or statement of
intention has been made by any of the parties which is not expressly embodied in
this  Agreement,  such other  agreements,  notes or instruments  related to this
transaction  executed  simultaneously   herewith,  or  the  written  statements,
certificates,  schedules or other documents delivered pursuant to this Agreement
or in connection with the transactions contemplated hereby.

      (e) Assignment.  Each party's rights and obligations  under this Agreement
shall not be assigned or delegated,  by operation of law or  otherwise,  without
the other party's prior consent, and any such assignment or attempted assignment
shall be void, of no force or effect, and shall constitute a material default by
such party.

      (f)  Amendments.  This Agreement may be amended,  modified,  superseded or
cancelled,  and any of the  terms,  covenants,  representations,  warranties  or
conditions hereof may be waived,  only by a written instrument  executed by each
party, in the case of a waiver, by the party waiving compliance.
<PAGE>

      (g)  Waivers.  The  failure  of any party at any time or times to  require
performance  of any  provision  hereof shall in no manner  affect the right at a
later time to enforce the same. No waiver by any party of any condition,  or the
breach of any term,  covenant,  representation  or  warranty  contained  in this
Agreement,  whether by conduct or otherwise,  in any one or more instances shall
be  deemed to be or  construed  as a further  or  continuing  waiver of any such
condition or breach or a waiver of any other term,  covenant,  representation or
warranty of this Agreement.

      IN WITNESS  WHEREOF,  the parties hereto have duly executed this Agreement
on the date first set forth above.

                                      AKID CORPORATION

                                      By:    /s/ Mechael Kanovsky
                                             -----------------------------------
                                      Name:  Mechael Kanovsky
                                      Title:

                                      /s/ Leonard Cohen
                                      ------------------------------------------
                                      LEONARD COHEN

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00091-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00091-of-00352.parquet"}]]